
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Effectiveness of Pyridoxal‐5′‐Phosphate in PNPO Deficiency: A Systematic Review - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="4DDE47ED89B729A31B47ED0005E6A5A9.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="blackwellopen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12317649/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Journal of Inherited Metabolic Disease">
<meta name="citation_title" content="Effectiveness of Pyridoxal‐5′‐Phosphate in PNPO Deficiency: A Systematic Review">
<meta name="citation_author" content="Nina N Stolwijk">
<meta name="citation_author_institution" content="Medicines for Society (Medicijn voor de Maatschappij), Platform at Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands">
<meta name="citation_author_institution" content="Department of Endocrinology and Metabolism. Amsterdam UMC, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Expertise Center for Inborn Errors of Metabolism, MetabERN, University of Amsterdam, Amsterdam, the Netherlands">
<meta name="citation_author" content="Laura van Dussen">
<meta name="citation_author_institution" content="Department of Endocrinology and Metabolism. Amsterdam UMC, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Expertise Center for Inborn Errors of Metabolism, MetabERN, University of Amsterdam, Amsterdam, the Netherlands">
<meta name="citation_author" content="Niels D Reijnhout">
<meta name="citation_author_institution" content="Medicines for Society (Medicijn voor de Maatschappij), Platform at Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands">
<meta name="citation_author" content="Marion M M G Brands">
<meta name="citation_author_institution" content="Department of Pediatrics, Division of Metabolic Diseases, Emma Children&#x27;s Hospital, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands">
<meta name="citation_author" content="Bregje Jaeger">
<meta name="citation_author_institution" content="Department of Child Neurology, Emma Children&#x27;s Hospital, Amsterdam University Medical Centers, Amsterdam, the Netherlands">
<meta name="citation_author" content="Peter T Clayton">
<meta name="citation_author_institution" content="Inborn Errors of Metabolism, Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London, UK">
<meta name="citation_author" content="Carla E M Hollak">
<meta name="citation_author_institution" content="Medicines for Society (Medicijn voor de Maatschappij), Platform at Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands">
<meta name="citation_author_institution" content="Department of Endocrinology and Metabolism. Amsterdam UMC, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Expertise Center for Inborn Errors of Metabolism, MetabERN, University of Amsterdam, Amsterdam, the Netherlands">
<meta name="citation_author" content="Annet M Bosch">
<meta name="citation_author_institution" content="Department of Pediatrics, Division of Metabolic Diseases, Emma Children&#x27;s Hospital, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands">
<meta name="citation_publication_date" content="2025 Aug 2">
<meta name="citation_volume" content="48">
<meta name="citation_issue" content="5">
<meta name="citation_firstpage" content="e70074">
<meta name="citation_doi" content="10.1002/jimd.70074">
<meta name="citation_pmid" content="40751583">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12317649/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12317649/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12317649/pdf/JIMD-48-0.pdf">
<meta name="description" content="Pyridox(am)ine 5′‐phosphate oxidase (PNPO) deficiency is an ultrarare inherited neurometabolic disease, characterized by primarily neonatal‐onset B6‐responsive epileptic encephalopathies. Treatment often requires sustainable access to high‐quality ...">
<meta name="og:title" content="Effectiveness of Pyridoxal‐5′‐Phosphate in PNPO Deficiency: A Systematic Review">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Pyridox(am)ine 5′‐phosphate oxidase (PNPO) deficiency is an ultrarare inherited neurometabolic disease, characterized by primarily neonatal‐onset B6‐responsive epileptic encephalopathies. Treatment often requires sustainable access to high‐quality ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12317649/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12317649">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1002/jimd.70074"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/JIMD-48-0.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12317649%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12317649/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12317649/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12317649/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-blackwellopen.png" alt="Wiley Open Access Collection logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Wiley Open Access Collection" title="Link to Wiley Open Access Collection" shape="default" href="https://doi.org/10.1002/jimd.70074" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">J Inherit Metab Dis</button></div>. 2025 Aug 2;48(5):e70074. doi: <a href="https://doi.org/10.1002/jimd.70074" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1002/jimd.70074</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22J%20Inherit%20Metab%20Dis%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%20Inherit%20Metab%20Dis%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J%20Inherit%20Metab%20Dis%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22J%20Inherit%20Metab%20Dis%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Effectiveness of Pyridoxal‐5′‐Phosphate in PNPO Deficiency: A Systematic Review</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stolwijk%20NN%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Nina N Stolwijk</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Nina N Stolwijk</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Medicines for Society (Medicijn voor de Maatschappij), Platform at Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>Department of Endocrinology and Metabolism. Amsterdam UMC, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Expertise Center for Inborn Errors of Metabolism, MetabERN, University of Amsterdam, Amsterdam, the Netherlands</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Stolwijk%20NN%22%5BAuthor%5D" class="usa-link"><span class="name western">Nina N Stolwijk</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22van%20Dussen%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Laura van Dussen</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Laura van Dussen</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Department of Endocrinology and Metabolism. Amsterdam UMC, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Expertise Center for Inborn Errors of Metabolism, MetabERN, University of Amsterdam, Amsterdam, the Netherlands</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22van%20Dussen%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Laura van Dussen</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Reijnhout%20ND%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Niels D Reijnhout</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Niels D Reijnhout</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Medicines for Society (Medicijn voor de Maatschappij), Platform at Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Reijnhout%20ND%22%5BAuthor%5D" class="usa-link"><span class="name western">Niels D Reijnhout</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Brands%20MMMG%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Marion M M G Brands</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Marion M M G Brands</span></h3>
<div class="p">
<sup>
<sup>3</sup>
</sup>Department of Pediatrics, Division of Metabolic Diseases, Emma Children's Hospital, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Brands%20MMMG%22%5BAuthor%5D" class="usa-link"><span class="name western">Marion M M G Brands</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jaeger%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Bregje Jaeger</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Bregje Jaeger</span></h3>
<div class="p">
<sup>
<sup>4</sup>
</sup>Department of Child Neurology, Emma Children's Hospital, Amsterdam University Medical Centers, Amsterdam, the Netherlands</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jaeger%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Bregje Jaeger</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Clayton%20PT%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Peter T Clayton</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Peter T Clayton</span></h3>
<div class="p">
<sup>
<sup>5</sup>
</sup>Inborn Errors of Metabolism, Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Clayton%20PT%22%5BAuthor%5D" class="usa-link"><span class="name western">Peter T Clayton</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hollak%20CEM%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Carla E M Hollak</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Carla E M Hollak</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Medicines for Society (Medicijn voor de Maatschappij), Platform at Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands</div>
<div class="p">
<sup>
<sup>2</sup>
</sup>Department of Endocrinology and Metabolism. Amsterdam UMC, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Expertise Center for Inborn Errors of Metabolism, MetabERN, University of Amsterdam, Amsterdam, the Netherlands</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hollak%20CEM%22%5BAuthor%5D" class="usa-link"><span class="name western">Carla E M Hollak</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bosch%20AM%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Annet M Bosch</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Annet M Bosch</span></h3>
<div class="p">
<sup>
<sup>3</sup>
</sup>Department of Pediatrics, Division of Metabolic Diseases, Emma Children's Hospital, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bosch%20AM%22%5BAuthor%5D" class="usa-link"><span class="name western">Annet M Bosch</span></a>
</div>
</div>
<sup>3,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="jimd70074-aff-0001">
<sup>
<sup>1</sup>
</sup>Medicines for Society (Medicijn voor de Maatschappij), Platform at Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands</div>
<div id="jimd70074-aff-0002">
<sup>
<sup>2</sup>
</sup>Department of Endocrinology and Metabolism. Amsterdam UMC, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Expertise Center for Inborn Errors of Metabolism, MetabERN, University of Amsterdam, Amsterdam, the Netherlands</div>
<div id="jimd70074-aff-0003">
<sup>
<sup>3</sup>
</sup>Department of Pediatrics, Division of Metabolic Diseases, Emma Children's Hospital, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM), Amsterdam UMC Location University of Amsterdam, Amsterdam, the Netherlands</div>
<div id="jimd70074-aff-0004">
<sup>
<sup>4</sup>
</sup>Department of Child Neurology, Emma Children's Hospital, Amsterdam University Medical Centers, Amsterdam, the Netherlands</div>
<div id="jimd70074-aff-0005">
<sup>
<sup>5</sup>
</sup>Inborn Errors of Metabolism, Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London, UK</div>
<div class="author-notes p">
<div class="fn" id="correspondenceTo">
<sup>*</sup><p class="display-inline">

<strong>Correspondence:</strong>
 
Annet M. Bosch (<span>a.m.bosch@amsterdamumc.nl</span>)
</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Revised 2025 Jul 23; Received 2025 May 20; Accepted 2025 Jul 26; Issue date 2025 Sep.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author(s). <em>Journal of Inherited Metabolic Disease</em> published by John Wiley &amp; Sons Ltd on behalf of SSIEM.</div>
<p>This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12317649  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40751583/" class="usa-link">40751583</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>ABSTRACT</h2>
<p>Pyridox(am)ine 5′‐phosphate oxidase (PNPO) deficiency is an ultrarare inherited neurometabolic disease, characterized by primarily neonatal‐onset B6‐responsive epileptic encephalopathies. Treatment often requires sustainable access to high‐quality pyridoxal‐5′‐phosphate (PLP, i.e., active vitamin B6), although some patients (also) respond to pyridoxine (PN). While PN is authorized as a medicinal product, PLP is not, and this forces reliance on lesser‐regulated food supplements, which risks dosing inaccuracies. This systematic review evaluates the effectiveness and safety of PLP in PNPO deficiency (PROSPERO, CRD42024542199). A systematic search was conducted in PubMed, Embase, and <a href="http://clinicaltrials.gov" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">ClinicalTrials.gov</a>, with risk of bias assessed and observational evidence summarized using a narrative synthesis approach. A total of 30 studies were included reporting on 49 patients treated with PLP. Clinical seizure responsiveness following PLP therapy was observed in the majority of patients (<em>n</em> = 38, 77.6%) and PLP treatment significantly improved survival (<em>p</em> &lt; 0.001) compared with untreated siblings with a similar phenotype. The majority of PLP‐responsive patients responded exclusively to PLP, with PN being attempted but ineffective in most of them (<em>n</em> = 30/33, 90.9%) Liver toxicity was the most frequently observed adverse event (<em>n</em> = 10, 20.4%) and although the underlying pathophysiological mechanism remains unclear, it may be associated with high‐dose PLP. Therefore, regular liver disease screening is recommended during PLP therapy. This means that PLP remains the only effective therapy for achieving and maintaining seizure control in the majority of PNPO deficient patients, but the therapeutic window for optimal management is narrow. Thus, it is essential to ensure patient access to high‐quality and appropriate forms of PLP.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> epileptic encephalopathy, PNPO deficiency, pyridoxal‐5′‐phosphate, treatment access, vitamin B6 disorders</p></section></section><section id="jimd70074-sec-0001"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Vitamin B6‐responsive epileptic encephalopathies are a group of rare inherited neurometabolic diseases characterized by early‐onset epileptic seizures resistant to common antiseizure medication(s) (ASM) but responsive to vitamin B6 vitamers. Despite the seeming simplicity of vitamin therapy, a lack of access to high‐quality pyridoxal‐5′‐phosphate (PLP)—the active form of vitamin B6—is known to complicate effective treatment [<a href="#jimd70074-bib-0001" class="usa-link" aria-describedby="jimd70074-bib-0001">1</a>, <a href="#jimd70074-bib-0002" class="usa-link" aria-describedby="jimd70074-bib-0002">2</a>]. Vitamin B6 consists of six interconvertible compounds, all sharing a central pyridine ring, with PLP and its precursor pyridoxine (PN) being of particular clinical importance [<a href="#jimd70074-bib-0003" class="usa-link" aria-describedby="jimd70074-bib-0003">3</a>]. PLP is an essential cofactor for numerous enzymatic reactions that include neurotransmitter synthesis and degradation, which explains why several inherited vitamin B6 disorders manifest with a predominantly neurological phenotype [<a href="#jimd70074-bib-0004" class="usa-link" aria-describedby="jimd70074-bib-0004">4</a>]. The enzyme pyridox(am)ine 5′‐phosphate oxidase (PNPO, EC 1.4.3.5) plays a key role in catalyzing the oxidation of phosphorylated forms of vitamin B6 to produce PLP [<a href="#jimd70074-bib-0005" class="usa-link" aria-describedby="jimd70074-bib-0005">5</a>]. In PNPO deficiency (OMIM #610090) this enzyme is dysfunctional due to pathogenic variants in the <em>PNPO</em> gene, resulting in a phenotype characterized by PN or PLP‐responsive neonatal epileptic encephalopathy (NEE) [<a href="#jimd70074-bib-0005" class="usa-link" aria-describedby="jimd70074-bib-0005">5</a>, <a href="#jimd70074-bib-0006" class="usa-link" aria-describedby="jimd70074-bib-0006">6</a>].</p>
<p>PN is widely available as a medicinal product, authorized by regulatory bodies such as the European Medicines Agency (EMA) and the American Food and Drug Administration (FDA). It is often effective for managing seizure disorders related to vitamin B6 metabolism, such as pyridoxine‐dependent epilepsy (PDE‐ALDH7A1, OMIM #266100) [<a href="#jimd70074-bib-0007" class="usa-link" aria-describedby="jimd70074-bib-0007">7</a>]. However, a review by Alghamdi et al. found that in 36% of PNPO patients, PN was not effective, and another 20% showed only a transient or incomplete response to PN [<a href="#jimd70074-bib-0008" class="usa-link" aria-describedby="jimd70074-bib-0008">8</a>]. In most PNPO patients, following neonatal epilepsy guidelines, PN therapy is initiated before PLP for seizures unresponsive to conventional ASM [<a href="#jimd70074-bib-0009" class="usa-link" aria-describedby="jimd70074-bib-0009">9</a>]. If PN fails, PLP is almost always needed, despite the fact that PLP is not authorized as medication.</p>
<p>This lack of authorized PLP medicinal products results in PNPO deficient patients depending on PLP food supplements to achieve seizure control, despite significant concerns about their appropriateness and reliability for this medical purpose [<a href="#jimd70074-bib-0001" class="usa-link" aria-describedby="jimd70074-bib-0001">1</a>, <a href="#jimd70074-bib-0002" class="usa-link" aria-describedby="jimd70074-bib-0002">2</a>]. This is particularly concerning, as PLP treatment necessitates strict dosing control: minor reductions or delays may result in seizures, whereas higher doses have been linked to liver toxicity [<a href="#jimd70074-bib-0010" class="usa-link" aria-describedby="jimd70074-bib-0010">10</a>, <a href="#jimd70074-bib-0011" class="usa-link" aria-describedby="jimd70074-bib-0011">11</a>]. Regulations for food supplements are usually less strict than those for medication, particularly concerning purity, concentration, and safety [<a href="#jimd70074-bib-0002" class="usa-link" aria-describedby="jimd70074-bib-0002">2</a>, <a href="#jimd70074-bib-0012" class="usa-link" aria-describedby="jimd70074-bib-0012">12</a>]. This reality also means PLP is not included in the regulatory or clinical monitoring systems that exist for authorized medication, and mechanisms to evaluate the long‐term safety of high‐dose treatment are lacking. We summarized all available data on the efficacy and safety of PLP in PNPO deficiency by conducting a systematic review of the literature to assess the unmet need for a PLP treatment option of reliable quality and accessibility [<a href="#jimd70074-bib-0013" class="usa-link" aria-describedby="jimd70074-bib-0013">13</a>].</p></section><section id="jimd70074-sec-0002"><h2 class="pmc_sec_title">2. Methods</h2>
<p>This systematic review was conducted according to the Preferred Reporting Items for Systematic Review and Meta‐Analyses (PRISMA) Guidelines and registered in the International Prospective Register for Systematic Reviews (CRD42024542199) [<a href="#jimd70074-bib-0014" class="usa-link" aria-describedby="jimd70074-bib-0014">14</a>].</p>
<section id="jimd70074-sec-0003"><h3 class="pmc_sec_title">2.1. Selection Criteria</h3>
<p>Studies were included in this systematic review if the efficacy and/or safety of PLP in any dose were reported in patients with PNPO deficiency. As PNPO deficiency was first recognized as the cause of PLP‐responsive epilepsy in 2005, studies published before that year were excluded [<a href="#jimd70074-bib-0006" class="usa-link" aria-describedby="jimd70074-bib-0006">6</a>]. Patients with vitamin B6‐responsive epileptic encephalopathy who underwent <em>PNPO</em> gene sequencing but had negative results were excluded, but cases with a single identified variant in the <em>PNPO</em> gene were included. Only studies with original data published in peer‐reviewed journals were included. Conference abstracts and studies in non‐English languages were excluded.</p></section><section id="jimd70074-sec-0004"><h3 class="pmc_sec_title">2.2. Search Strategy</h3>
<p>A comprehensive search using controlled terms and free text terms for the concepts (1) PLP (including its abbreviations and different spellings) and (2) PNPO deficiency (including its abbreviations and different spellings) or (3) its clinical presentation, for example, epileptic encephalopathy (or similar terms, including epilepsy, seizures) was performed in the PubMed and Embase databases and in the clinical trial registry database <a href="http://clinicaltrials.gov" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">ClinicalTrials.gov</a>. The search was performed on 15 April 2024. We also performed a hand search of reference lists of included studies and reviewed relevant articles mentioned in excluded reviews for potentially relevant case reports. In the Supporting Information <a href="#jimd70074-supitem-0001" class="usa-link">S1</a>, the complete search strategy is presented. The identified records were imported into the reference management tool Endnote (X9.2; Clarivate Analytics, Philadelphia, PA) and duplicates were removed.</p></section><section id="jimd70074-sec-0005"><h3 class="pmc_sec_title">2.3. Study Selection and Critical Appraisal</h3>
<p>Titles, abstracts, and the subsequently obtained relevant full‐text articles were independently evaluated for eligibility by two reviewers per article (N.D.R. and N.N.S.) for eligibility using Rayyan (Qatar Computing Research Institute, Doha, Qatar) [<a href="#jimd70074-bib-0015" class="usa-link" aria-describedby="jimd70074-bib-0015">15</a>]. The assessment of methodological quality and risk of bias was also conducted independently by two members of the data extraction team (L.v.D., N.D.R., and N.N.S.); any discrepancies were resolved via discussion. The tool developed by Murad et al. was utilized to assess risk of bias for case reports and case series [<a href="#jimd70074-bib-0016" class="usa-link" aria-describedby="jimd70074-bib-0016">16</a>].</p></section><section id="jimd70074-sec-0006"><h3 class="pmc_sec_title">2.4. Data Collection and Analysis</h3>
<p>Baseline characteristics, PLP therapy details (e.g., age of initiation, daily dose, dose adjustments), duration of follow‐up, and outcomes were extracted independently by two reviewers per study (L.v.D., N.D.R., and N.N.S.). A standardized extraction form in Castor EDC (Castor v2023.4.4.0) was used to facilitate this, and discrepancies were resolved by discussion. Seizure responsiveness to PLP therapy was assessed on a 5‐point scale (no response, complete cessation, improvement, stabilization, worsening). Developmental outcomes were categorized based on the classifications provided by the authors of each publication.</p>
<p>Adverse events were scored according to the definitions of the Common Terminology Criteria for Adverse Events (CTCAE) v5.0; no grading was applied.</p>
<p>Data were processed and analyzed using Excel and R version 4.3.1. Kaplan–Meier curves and a log‐rank test were employed in subgroup analyses to assess survival rates.</p></section></section><section id="jimd70074-sec-0007"><h2 class="pmc_sec_title">3. Results</h2>
<p>A total of 1049 studies were identified through the literature search. After removing 265 duplicates, 782 studies were screened on title and abstract (Figure <a href="#jimd70074-fig-0001" class="usa-link">1</a>). Of these, 80 studies were selected for full‐text review and 30 met the inclusion criteria [<a href="#jimd70074-bib-0002" class="usa-link" aria-describedby="jimd70074-bib-0002">2</a>, <a href="#jimd70074-bib-0006" class="usa-link" aria-describedby="jimd70074-bib-0006">6</a>, <a href="#jimd70074-bib-0010" class="usa-link" aria-describedby="jimd70074-bib-0010">10</a>, <a href="#jimd70074-bib-0011" class="usa-link" aria-describedby="jimd70074-bib-0011">11</a>, <a href="#jimd70074-bib-0013" class="usa-link" aria-describedby="jimd70074-bib-0013">13</a>, <a href="#jimd70074-bib-0017" class="usa-link" aria-describedby="jimd70074-bib-0017">17</a>, <a href="#jimd70074-bib-0018" class="usa-link" aria-describedby="jimd70074-bib-0018">18</a>, <a href="#jimd70074-bib-0019" class="usa-link" aria-describedby="jimd70074-bib-0019">19</a>, <a href="#jimd70074-bib-0020" class="usa-link" aria-describedby="jimd70074-bib-0020">20</a>, <a href="#jimd70074-bib-0021" class="usa-link" aria-describedby="jimd70074-bib-0021">21</a>, <a href="#jimd70074-bib-0022" class="usa-link" aria-describedby="jimd70074-bib-0022">22</a>, <a href="#jimd70074-bib-0023" class="usa-link" aria-describedby="jimd70074-bib-0023">23</a>, <a href="#jimd70074-bib-0024" class="usa-link" aria-describedby="jimd70074-bib-0024">24</a>, <a href="#jimd70074-bib-0025" class="usa-link" aria-describedby="jimd70074-bib-0025">25</a>, <a href="#jimd70074-bib-0026" class="usa-link" aria-describedby="jimd70074-bib-0026">26</a>, <a href="#jimd70074-bib-0027" class="usa-link" aria-describedby="jimd70074-bib-0027">27</a>, <a href="#jimd70074-bib-0028" class="usa-link" aria-describedby="jimd70074-bib-0028">28</a>, <a href="#jimd70074-bib-0029" class="usa-link" aria-describedby="jimd70074-bib-0029">29</a>, <a href="#jimd70074-bib-0030" class="usa-link" aria-describedby="jimd70074-bib-0030">30</a>, <a href="#jimd70074-bib-0031" class="usa-link" aria-describedby="jimd70074-bib-0031">31</a>, <a href="#jimd70074-bib-0032" class="usa-link" aria-describedby="jimd70074-bib-0032">32</a>, <a href="#jimd70074-bib-0033" class="usa-link" aria-describedby="jimd70074-bib-0033">33</a>, <a href="#jimd70074-bib-0034" class="usa-link" aria-describedby="jimd70074-bib-0034">34</a>, <a href="#jimd70074-bib-0035" class="usa-link" aria-describedby="jimd70074-bib-0035">35</a>, <a href="#jimd70074-bib-0036" class="usa-link" aria-describedby="jimd70074-bib-0036">36</a>, <a href="#jimd70074-bib-0037" class="usa-link" aria-describedby="jimd70074-bib-0037">37</a>, <a href="#jimd70074-bib-0038" class="usa-link" aria-describedby="jimd70074-bib-0038">38</a>, <a href="#jimd70074-bib-0039" class="usa-link" aria-describedby="jimd70074-bib-0039">39</a>, <a href="#jimd70074-bib-0040" class="usa-link" aria-describedby="jimd70074-bib-0040">40</a>, <a href="#jimd70074-bib-0041" class="usa-link" aria-describedby="jimd70074-bib-0041">41</a>]. Reasons for exclusion are shown in Figure <a href="#jimd70074-fig-0001" class="usa-link">1</a>. All 30 included studies were either case series or case reports; 2 (6.6%) were considered low risk, 15 (50%) moderate risk, and 13 (43.3%) high risk of bias (see Supporting Information <a href="#jimd70074-supitem-0001" class="usa-link">S1</a> for an overview).</p>
<figure class="fig xbox font-sm" id="jimd70074-fig-0001"><h3 class="obj_head">FIGURE 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/489a/12317649/d58e09a60cd0/JIMD-48-0-g001.jpg" loading="lazy" id="jats-graphic-1" height="526" width="709" alt="FIGURE 1"></p>
<div class="p text-right font-secondary"><a href="figure/jimd70074-fig-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Preferred reporting items for systematic reviews and meta‐analysis flow diagram.</p></figcaption></figure><section id="jimd70074-sec-0008"><h3 class="pmc_sec_title">3.1. Baseline Characteristics</h3>
<p>A total of 49 patients with PNPO deficiency were reported to have been treated with PLP. Sex was documented for 47 patients, with the majority being male (<em>n</em> = 33, 70.2%). For 45 patients, biallelic variants in the <em>PNPO</em> gene were reported. In four patients, a single heterozygous <em>PNPO</em> variant was found [<a href="#jimd70074-bib-0002" class="usa-link" aria-describedby="jimd70074-bib-0002">2</a>, <a href="#jimd70074-bib-0021" class="usa-link" aria-describedby="jimd70074-bib-0021">21</a>, <a href="#jimd70074-bib-0031" class="usa-link" aria-describedby="jimd70074-bib-0031">31</a>, <a href="#jimd70074-bib-0036" class="usa-link" aria-describedby="jimd70074-bib-0036">36</a>]. Age of onset was recorded for 48 patients, with one patient treated before the appearance of symptoms because of a prior PNPO deficiency diagnosis in a sibling [<a href="#jimd70074-bib-0028" class="usa-link" aria-describedby="jimd70074-bib-0028">28</a>, <a href="#jimd70074-bib-0031" class="usa-link" aria-describedby="jimd70074-bib-0031">31</a>]. The median age of seizure onset was day 1 of life (range 0.5 h to 17 months) and the median age at last follow up was 3 years (range 48 days to 21 years). The duration of PLP use was recorded for 27 patients with a mean of 3 years (range 6 days to 11 years).</p></section><section id="jimd70074-sec-0009"><h3 class="pmc_sec_title">3.2. Clinical Seizure Responsiveness</h3>
<p>In a total of 38 patients (77.6%) PLP therapy was reported to be effective (see Table <a href="#jimd70074-tbl-0001" class="usa-link">1</a> for an overview). In 27 patients PLP therapy led to complete seizure cessation (with the possible exception for seizures occurring during febrile illness) while another 10 patients showed an improvement in seizure frequency. The one presymptomatic patient who received PLP therapy from birth achieved complete seizure control, apart from two seizures at 10 and 11 months old [<a href="#jimd70074-bib-0028" class="usa-link" aria-describedby="jimd70074-bib-0028">28</a>]. The median PLP dosage (including dose adjustments) for PLP‐responsive patients was 35.5 mg/kg/day (range: 10–74) and the median age of PLP initiation was 30 days (range: 0 day to 19 years). The effectiveness of PLP in achieving adequate seizure control in PNPO deficiency is further supported by the fact that 26 (68.4%) of the patients who responded to PLP received monotherapy. Additionally, in 12 patients a dose–response effect related to PLP was reported. These reports included dose increases that reduced seizure frequency as well as seizure recurrences at the end of a dose interval. In another 7 patients, a challenge–rechallenge effect occurred, with seizure recurrence following PLP withdrawal.</p>
<section class="tw xbox font-sm" id="jimd70074-tbl-0001"><h4 class="obj_head">TABLE 1.</h4>
<div class="caption p"><p>Seizure response following PLP therapy.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Seizures</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">PLP‐responsive</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Total (<em>n</em>, %)</td>
<td align="center" valign="top" rowspan="1" colspan="1">38 (77.6)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">PLP treatment</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Age at PLP initiation (median, range) (days, years)</td>
<td align="center" valign="top" rowspan="1" colspan="1">30 days (0 day to 19 years)<a href="#jimd70074-note-0003" class="usa-link">
<sup>a</sup>
</a>
</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">PLP dosage<a href="#jimd70074-note-0004" class="usa-link">
<sup>b</sup>
</a> (median, range) (mg/kg/day)</td>
<td align="center" valign="top" rowspan="1" colspan="1">35.5 (10–74)<a href="#jimd70074-note-0003" class="usa-link">
<sup>a</sup>
</a>
</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">PLP monotherapy (<em>n</em>, %)</td>
<td align="center" valign="top" rowspan="1" colspan="1">26 (68.4)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">PN treatment</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Attempted (<em>n</em>, %)</td>
<td align="center" valign="top" rowspan="1" colspan="1">33 (86.8)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">No or insufficient response (<em>n</em>, %)</td>
<td align="center" valign="top" rowspan="1" colspan="1">30 (90.9)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/jimd70074-tbl-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="jimd70074-note-0002"><p>Abbreviations: PLP, pyridoxal‐5′‐phosphate; PN, pyridoxine.</p></div>
<div class="fn" id="jimd70074-note-0003">
<sup>
<sup>a</sup>
</sup><p class="display-inline">
<em>n</em> = 25.</p>
</div>
<div class="fn" id="jimd70074-note-0004">
<sup>
<sup>b</sup>
</sup><p class="display-inline">Including dose adjustments.</p>
</div>
</div></section></section><section id="jimd70074-sec-0010"><h3 class="pmc_sec_title">3.3. No or Unclear Seizure Responsiveness</h3>
<p>Seven patients (14.3%) did not demonstrate a clinical response to PLP therapy. One patient showed no response, while 6 patients experienced an increase in seizure frequency after switching from PN to PLP (see Table <a href="#jimd70074-tbl-0002" class="usa-link">2</a> for an overview) [<a href="#jimd70074-bib-0022" class="usa-link" aria-describedby="jimd70074-bib-0022">22</a>, <a href="#jimd70074-bib-0029" class="usa-link" aria-describedby="jimd70074-bib-0029">29</a>, <a href="#jimd70074-bib-0031" class="usa-link" aria-describedby="jimd70074-bib-0031">31</a>, <a href="#jimd70074-bib-0034" class="usa-link" aria-describedby="jimd70074-bib-0034">34</a>]. All of these patients had biallelic <em>PNPO</em> variants. Limited data were available on the characteristics of PLP therapy in these patients: PLP dosage was reported for only 2 of 7 patients, and age at initiation was documented for 4.</p>
<section class="tw xbox font-sm" id="jimd70074-tbl-0002"><h4 class="obj_head">TABLE 2.</h4>
<div class="caption p"><p>PNPO deficiency patients with no PLP response or worsened seizures after PN to PLP switch.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000">
<th align="left" rowspan="2" valign="bottom" colspan="1">Reference (first author, year)</th>
<th align="center" rowspan="2" valign="bottom" colspan="1">Patient no. in original publication</th>
<th align="center" colspan="2" valign="bottom" rowspan="1">Patient characteristics</th>
<th align="center" colspan="3" valign="bottom" rowspan="1">PLP treatment</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">PN treatment</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Outcomes</th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="center" valign="bottom" rowspan="1" colspan="1">PNPO variants</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Seizure onset</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">PLP response</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Age at PLP initiation</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">PLP dosage (mg/kg/day)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">PN response</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Treatment at the time of publication, outcome</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Mills (2014) [<a href="#jimd70074-bib-0031" class="usa-link" aria-describedby="jimd70074-bib-0031">31</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">9</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.98A&gt;T (homozygous)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 weeks</td>
<td align="center" valign="top" rowspan="1" colspan="1">↑</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 years</td>
<td align="center" valign="top" rowspan="1" colspan="1">10</td>
<td align="center" valign="top" rowspan="1" colspan="1">+</td>
<td align="center" valign="top" rowspan="1" colspan="1">PN monotherapy, mild developmental delay</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">14</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.347G&gt;A; c.674G&gt;A (homozygous)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.5 h</td>
<td align="center" valign="top" rowspan="1" colspan="1">↑</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 years</td>
<td align="center" valign="top" rowspan="1" colspan="1">NR</td>
<td align="center" valign="top" rowspan="1" colspan="1">+</td>
<td align="center" valign="top" rowspan="1" colspan="1">PN monotherapy, mild developmental delay</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">15</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.347G&gt;A; c.674G&gt;A (homozygous)</td>
<td align="center" valign="top" rowspan="1" colspan="1">10 h</td>
<td align="center" valign="top" rowspan="1" colspan="1">↑</td>
<td align="center" valign="top" rowspan="1" colspan="1">8 years</td>
<td align="center" valign="top" rowspan="1" colspan="1">NR</td>
<td align="center" valign="top" rowspan="1" colspan="1">+</td>
<td align="center" valign="top" rowspan="1" colspan="1">PN monotherapy, developmental delay</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Plecko et al. (2014) [<a href="#jimd70074-bib-0034" class="usa-link" aria-describedby="jimd70074-bib-0034">34</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">1b</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.347G&gt;A; c.674G&gt;A (homozygous)<a href="#jimd70074-note-0006" class="usa-link">
<sup>a</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 day</td>
<td align="center" valign="top" rowspan="1" colspan="1">↑</td>
<td align="center" valign="top" rowspan="1" colspan="1">NR</td>
<td align="center" valign="top" rowspan="1" colspan="1">NR</td>
<td align="center" valign="top" rowspan="1" colspan="1">+</td>
<td align="center" valign="top" rowspan="1" colspan="1">PN monotherapy, developmental delay</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1">2b</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.347G&gt;A; c.674G&gt;A (homozygous)<a href="#jimd70074-note-0006" class="usa-link">
<sup>a</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 h</td>
<td align="center" valign="top" rowspan="1" colspan="1">↑</td>
<td align="center" valign="top" rowspan="1" colspan="1">NR</td>
<td align="center" valign="top" rowspan="1" colspan="1">NR</td>
<td align="center" valign="top" rowspan="1" colspan="1">±</td>
<td align="center" valign="top" rowspan="1" colspan="1">PN + levetiracetam, recurrent breakthrough seizures in infancy, developmental delay</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Farmania et al. (2021) [<a href="#jimd70074-bib-0022" class="usa-link" aria-describedby="jimd70074-bib-0022">22</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">Only case</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.482G&gt;A (homozygous)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 h</td>
<td align="center" valign="top" rowspan="1" colspan="1">—</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 days</td>
<td align="center" valign="top" rowspan="1" colspan="1">30</td>
<td align="center" valign="top" rowspan="1" colspan="1">±</td>
<td align="center" valign="top" rowspan="1" colspan="1">NA, death at 56th day of life</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Jiao et al. (2023) [<a href="#jimd70074-bib-0029" class="usa-link" aria-describedby="jimd70074-bib-0029">29</a>]</td>
<td align="center" valign="top" rowspan="1" colspan="1">11</td>
<td align="center" valign="top" rowspan="1" colspan="1">c.448_451del+c.481C&gt;T (compound heterozygous)</td>
<td align="center" valign="top" rowspan="1" colspan="1">12 days</td>
<td align="center" valign="top" rowspan="1" colspan="1">↑</td>
<td align="center" valign="top" rowspan="1" colspan="1">NR</td>
<td align="center" valign="top" rowspan="1" colspan="1">NR</td>
<td align="center" valign="top" rowspan="1" colspan="1">±</td>
<td align="center" valign="top" rowspan="1" colspan="1">PN + levetiracetam, occasional seizures</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/jimd70074-tbl-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="jimd70074-note-0005"><p>Abbreviations: —, no response; +, good seizure response; ±, partial or transient seizure response; ↑, seizure increase following switch from PN to PLP; NA, not applicable; NR, not reported; PLP, pyridoxal‐5′‐phosphate; PN, pyridoxine.</p></div>
<div class="fn" id="jimd70074-note-0006">
<sup>
<sup>a</sup>
</sup><p class="display-inline">Additional PNPO polymorphisms reported.</p>
</div>
</div></section><p>In four additional patients, the clinical seizure response to PLP therapy was unclear. One child started on PLP (50 mg/kg/day) while already in poor condition due to ongoing seizure activity and multiorgan dysfunction briefly improved following PLP therapy but died after his condition deteriorated and seizures recurred [<a href="#jimd70074-bib-0013" class="usa-link" aria-describedby="jimd70074-bib-0013">13</a>]. In two twins with poor seizure control on PN, switching to PLP caused an initial increase in seizures, followed by stabilization at a seizure frequency comparable to the frequency on PN. They were switched back to PN due to persistent vomiting and loss of appetite attributed to PLP use [<a href="#jimd70074-bib-0029" class="usa-link" aria-describedby="jimd70074-bib-0029">29</a>, <a href="#jimd70074-bib-0030" class="usa-link" aria-describedby="jimd70074-bib-0030">30</a>, <a href="#jimd70074-bib-0041" class="usa-link" aria-describedby="jimd70074-bib-0041">41</a>]. Finally, one patient experienced refractory status epilepticus when PLP therapy was first introduced and the existing PN therapy was tapered [<a href="#jimd70074-bib-0032" class="usa-link" aria-describedby="jimd70074-bib-0032">32</a>]. PN therapy and three ASM were reinstated, but seizure control remained poor. Two years later, seizure control improved with the addition of PLP (10 mg/kg/day) and riboflavin to the treatment regimen, which already included PN and three ASM.</p></section><section id="jimd70074-sec-0011"><h3 class="pmc_sec_title">3.4. 
PN Therapy</h3>
<p>In the majority of PLP‐responsive patients, a PN trial was also attempted (<em>n</em> = 33, 86.8%) [<a href="#jimd70074-bib-0002" class="usa-link" aria-describedby="jimd70074-bib-0002">2</a>, <a href="#jimd70074-bib-0006" class="usa-link" aria-describedby="jimd70074-bib-0006">6</a>, <a href="#jimd70074-bib-0017" class="usa-link" aria-describedby="jimd70074-bib-0017">17</a>, <a href="#jimd70074-bib-0018" class="usa-link" aria-describedby="jimd70074-bib-0018">18</a>, <a href="#jimd70074-bib-0021" class="usa-link" aria-describedby="jimd70074-bib-0021">21</a>, <a href="#jimd70074-bib-0023" class="usa-link" aria-describedby="jimd70074-bib-0023">23</a>, <a href="#jimd70074-bib-0024" class="usa-link" aria-describedby="jimd70074-bib-0024">24</a>, <a href="#jimd70074-bib-0025" class="usa-link" aria-describedby="jimd70074-bib-0025">25</a>, <a href="#jimd70074-bib-0026" class="usa-link" aria-describedby="jimd70074-bib-0026">26</a>, <a href="#jimd70074-bib-0027" class="usa-link" aria-describedby="jimd70074-bib-0027">27</a>, <a href="#jimd70074-bib-0029" class="usa-link" aria-describedby="jimd70074-bib-0029">29</a>, <a href="#jimd70074-bib-0030" class="usa-link" aria-describedby="jimd70074-bib-0030">30</a>, <a href="#jimd70074-bib-0031" class="usa-link" aria-describedby="jimd70074-bib-0031">31</a>, <a href="#jimd70074-bib-0033" class="usa-link" aria-describedby="jimd70074-bib-0033">33</a>, <a href="#jimd70074-bib-0035" class="usa-link" aria-describedby="jimd70074-bib-0035">35</a>, <a href="#jimd70074-bib-0036" class="usa-link" aria-describedby="jimd70074-bib-0036">36</a>, <a href="#jimd70074-bib-0038" class="usa-link" aria-describedby="jimd70074-bib-0038">38</a>, <a href="#jimd70074-bib-0039" class="usa-link" aria-describedby="jimd70074-bib-0039">39</a>, <a href="#jimd70074-bib-0040" class="usa-link" aria-describedby="jimd70074-bib-0040">40</a>, <a href="#jimd70074-bib-0042" class="usa-link" aria-describedby="jimd70074-bib-0042">42</a>]. Most of these patients, however, did not achieve adequate seizure control following PN therapy (<em>n</em> = 30, 90.9%): 20 patients showed no response, 4 had an initial response followed by seizure recurrence, and 6 experienced partial control with breakthrough seizures. Two patients did have a favorable response to PN monotherapy. One of these patients was switched to PN after experiencing gastrointestinal side effects (vomiting, epigastric pain) during PLP therapy. Another patient was treated with PN, but this treatment was discontinued for unknown reasons, and the patient was then restarted on levetiracetam following seizure recurrence, with PLP therapy initiated following PNPO deficiency diagnosis [<a href="#jimd70074-bib-0021" class="usa-link" aria-describedby="jimd70074-bib-0021">21</a>, <a href="#jimd70074-bib-0023" class="usa-link" aria-describedby="jimd70074-bib-0023">23</a>]. In one patient, the response to PN therapy was unclear [<a href="#jimd70074-bib-0025" class="usa-link" aria-describedby="jimd70074-bib-0025">25</a>].</p>
<p>Five of the seven patients who did not show PLP‐responsiveness achieved good seizure control on PN therapy. A partial response to PN was observed in one patient, who is maintained on PN and levetiracetam, though occasional seizures persist [<a href="#jimd70074-bib-0029" class="usa-link" aria-describedby="jimd70074-bib-0029">29</a>]. Lastly, in one patient, adequate seizure control was not achieved with either PN or PLP, and this patient died [<a href="#jimd70074-bib-0022" class="usa-link" aria-describedby="jimd70074-bib-0022">22</a>].</p></section><section id="jimd70074-sec-0012"><h3 class="pmc_sec_title">3.5. Development</h3>
<p>Developmental outcomes in PLP‐responsive patients on monotherapy were assessed to evaluate the impact of PLP on development (see Table <a href="#jimd70074-tbl-0003" class="usa-link">3</a>.) The level of development was reported for most of these patients (<em>n</em> = 24). Normal neurodevelopment was documented by the reporting authors for 10 (41.7%) of these patients, 6 (25.0%) showed a minor to moderate delay, and a severe delay was noted for 8 (30.3%) patients. For one additional patient, a delay was noted without specification of its severity [<a href="#jimd70074-bib-0002" class="usa-link" aria-describedby="jimd70074-bib-0002">2</a>]. For the patients with normal neurodevelopment to moderate developmental delays, PLP appears to have been initiated earlier (Table <a href="#jimd70074-tbl-0003" class="usa-link">3</a>.) than for the patients with a severe delay. It should be noted, however, that the age of PLP initiation was only documented for half of the patients with a severe delay on PLP monotherapy. For 6 of the 10 PLP monotherapy patients with normal neurodevelopment, PLP therapy was initiated in the neonatal period. This was true for only one patient with a severe delay.</p>
<section class="tw xbox font-sm" id="jimd70074-tbl-0003"><h4 class="obj_head">TABLE 3.</h4>
<div class="caption p"><p>Developmental outcomes in PLP‐responsive patients on monotherapy.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1"></th>
<th align="center" valign="bottom" rowspan="1" colspan="1">No. of patients (<em>n</em>, %)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Age of PLP initiation; median, range (days, months, years)</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" style="background-color:#F2F2F2" valign="top" rowspan="1" colspan="1">Neurodevelopment</td>
<td align="center" style="background-color:#F2F2F2" valign="top" rowspan="1" colspan="1">
<em>n</em> = 24</td>
<td align="center" style="background-color:#F2F2F2" valign="top" rowspan="1" colspan="1">
<em>n</em> = 17</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Normal</td>
<td align="center" valign="top" rowspan="1" colspan="1">10 (41.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">20 days (0 day to 5 months)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Minor/moderate delay</td>
<td align="center" valign="top" rowspan="1" colspan="1">6 (25.0)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 days (3 days to 3.5 months)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Severe delay</td>
<td align="center" valign="top" rowspan="1" colspan="1">8 (30.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 years (5 days to 19 years)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/jimd70074-tbl-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="jimd70074-note-0007"><p>Abbreviation: PLP, pyridoxal‐5′‐phosphate.</p></div></div></section></section><section id="jimd70074-sec-0013"><h3 class="pmc_sec_title">3.6. Survival</h3>
<p>Death was reported in three PLP‐treated patients. Two of these patients had undergone unsuccessful PLP trials and were on PN therapy at the time of death. The first of these patients, who passed away on the 56th day of life, suffered from seizures that did not improve with trials of PN (100 mg IV), PLP (30 mg/kg/day), or ASM [<a href="#jimd70074-bib-0022" class="usa-link" aria-describedby="jimd70074-bib-0022">22</a>]. The second patient died of therapy‐resistant seizures at 8 years of age [<a href="#jimd70074-bib-0029" class="usa-link" aria-describedby="jimd70074-bib-0029">29</a>, <a href="#jimd70074-bib-0030" class="usa-link" aria-describedby="jimd70074-bib-0030">30</a>, <a href="#jimd70074-bib-0041" class="usa-link" aria-describedby="jimd70074-bib-0041">41</a>]. It is unclear if the third deceased patient, with poorly controlled seizures despite a transient EEG response to PLP (50 mg/kg/day, initiated at 23 days old), was still on PLP therapy at the time of death, which was due to a fungal infection at 48 days amid multiorgan dysfunction [<a href="#jimd70074-bib-0013" class="usa-link" aria-describedby="jimd70074-bib-0013">13</a>].</p>
<p>For 9 patients included, previous siblings had exhibited comparable convulsive symptoms but did not receive PLP (because the diagnosis of PNPO deficiency was not yet established) [<a href="#jimd70074-bib-0006" class="usa-link" aria-describedby="jimd70074-bib-0006">6</a>, <a href="#jimd70074-bib-0017" class="usa-link" aria-describedby="jimd70074-bib-0017">17</a>, <a href="#jimd70074-bib-0018" class="usa-link" aria-describedby="jimd70074-bib-0018">18</a>, <a href="#jimd70074-bib-0027" class="usa-link" aria-describedby="jimd70074-bib-0027">27</a>, <a href="#jimd70074-bib-0031" class="usa-link" aria-describedby="jimd70074-bib-0031">31</a>, <a href="#jimd70074-bib-0034" class="usa-link" aria-describedby="jimd70074-bib-0034">34</a>]. The impact of PLP treatment on survival was evident: of the siblings who did not receive PLP, 10 died, with survival times available for 9 (median age at death 32.6 days, range 7 days to 7 months). In contrast, their PLP‐treated siblings treated with PLP survived (<em>p</em> &lt; 0.001, with ages at last follow‐up available for 7 siblings). Seizure control was achieved with PN therapy in the only surviving sibling from the untreated group, while three of the deceased siblings had also received PN therapy without effect [<a href="#jimd70074-bib-0018" class="usa-link" aria-describedby="jimd70074-bib-0018">18</a>, <a href="#jimd70074-bib-0034" class="usa-link" aria-describedby="jimd70074-bib-0034">34</a>].</p></section><section id="jimd70074-sec-0014"><h3 class="pmc_sec_title">3.7. Safety</h3>
<p>Adverse events were reported in 15 patients on PLP therapy (30.6%, see Table <a href="#jimd70074-tbl-0004" class="usa-link">4</a>). The most frequently reported adverse events related to liver toxicity, with elevated transaminases reported in 10 patients (20.4%). Nine of these patients had been on long‐term PLP therapy (&gt; 1 year). In two of these patients, liver cirrhosis occurred and was confirmed by liver biopsy [<a href="#jimd70074-bib-0010" class="usa-link" aria-describedby="jimd70074-bib-0010">10</a>, <a href="#jimd70074-bib-0011" class="usa-link" aria-describedby="jimd70074-bib-0011">11</a>]. Both patients required high‐dose (50–100 mg/kg/day) PLP therapy to maintain seizure control and had been on PLP for several years before cirrhosis developed. In one other patient, acute liver failure was reported and related to CMV‐related hepatopathy [<a href="#jimd70074-bib-0031" class="usa-link" aria-describedby="jimd70074-bib-0031">31</a>]. Treatment with ursodeoxycholic acid was initiated, and elevated transaminases have since persisted.</p>
<section class="tw xbox font-sm" id="jimd70074-tbl-0004"><h4 class="obj_head">TABLE 4.</h4>
<div class="caption p"><p>Overview of adverse events during PLP therapy.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1"></th>
<th align="center" valign="bottom" rowspan="1" colspan="1">No. of patients with the AE (<em>n</em>, %)</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" style="background-color:#F2F2F2" valign="top" rowspan="1" colspan="1">Hepatic</td>
<td align="center" style="background-color:#F2F2F2" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Elevated transaminases</td>
<td align="center" valign="top" rowspan="1" colspan="1">10 (20.4%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Liver cirrhosis</td>
<td align="center" valign="top" rowspan="1" colspan="1">2 (4.1%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Acute liver failure<a href="#jimd70074-note-0009" class="usa-link">
<sup>a</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (2.0%)</td>
</tr>
<tr>
<td align="left" style="background-color:#F2F2F2" valign="top" rowspan="1" colspan="1">Gastrointestinal</td>
<td align="center" style="background-color:#F2F2F2" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Vomiting</td>
<td align="center" valign="top" rowspan="1" colspan="1">4 (8.2%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Feeding difficulties</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (6.1%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Epigastric pain</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (2.0%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Gastritis</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (2.0%)</td>
</tr>
<tr>
<td align="left" style="background-color:#F2F2F2" valign="top" rowspan="1" colspan="1">Other</td>
<td align="center" style="background-color:#F2F2F2" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Administration difficulties</td>
<td align="center" valign="top" rowspan="1" colspan="1">3 (6.1%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">PLP intoxication</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (2.0%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Somnolence</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (2.0%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Increased bleeding<a href="#jimd70074-note-0010" class="usa-link">
<sup>b</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">1 (2.0%)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/jimd70074-tbl-0004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="jimd70074-note-0008"><p>Abbreviation: AE, adverse event.</p></div>
<div class="fn" id="jimd70074-note-0009">
<sup>
<sup>a</sup>
</sup><p class="display-inline">Due to CMV‐related hepatopathy.</p>
</div>
<div class="fn" id="jimd70074-note-0010">
<sup>
<sup>b</sup>
</sup><p class="display-inline">In patient with mild hemophilia type A.</p>
</div>
</div></section><p>An additional 8 gastrointestinal adverse events were reported (vomiting <em>n</em> = 4, feeding difficulties <em>n</em> = 3, epigastric pain <em>n</em> = 1). Three instances of PLP administration difficulties were noted, which related to the required intake of a high volume of PLP in two cases [<a href="#jimd70074-bib-0002" class="usa-link" aria-describedby="jimd70074-bib-0002">2</a>, <a href="#jimd70074-bib-0026" class="usa-link" aria-describedby="jimd70074-bib-0026">26</a>]. In one patient, PLP intoxication occurred due to unclear labeling of a PLP food supplement, resulting in an unintended dosage of 74 mg/kg/day [<a href="#jimd70074-bib-0002" class="usa-link" aria-describedby="jimd70074-bib-0002">2</a>]. In another, somnolence was reported on a PLP dose of 50 mg/kg/day, which improved following a dose reduction [<a href="#jimd70074-bib-0024" class="usa-link" aria-describedby="jimd70074-bib-0024">24</a>]. In one patient with mild hemophilia type A in addition to PNPO deficiency, an increase in bleeding symptoms was noted [<a href="#jimd70074-bib-0020" class="usa-link" aria-describedby="jimd70074-bib-0020">20</a>].</p></section></section><section id="jimd70074-sec-0015"><h2 class="pmc_sec_title">4. Discussion</h2>
<p>This systematic review evaluated the effectiveness and safety of PLP in patients with PNPO deficiency. The findings suggest that PLP therapy effectively achieves and maintains seizure control in most PNPO deficient patients and significantly improves survival compared with untreated siblings with a similar phenotype. Nearly all patients with PLP‐responsive seizures were dependent on PLP, as their seizures did not respond to PN therapy. The therapeutic window for effective PLP treatment seems narrow, with reports of seizure recurrence at the end of a dosing interval or following a single missed dose, potentially exacerbated by PLP supplements with unreliable dose accuracy [<a href="#jimd70074-bib-0001" class="usa-link" aria-describedby="jimd70074-bib-0001">1</a>]. However, dosing increases must be considered carefully, as there is evidence that long‐term and high‐dose PLP usage is associated with hepatotoxicity. Despite this risk, for PNPO deficiency patients with PLP‐responsive but PN‐resistant seizures, at present, PLP remains the only viable treatment option; the prognosis for patients with an insufficient response to both PN and PLP appears to be poor.</p>
<p>Not all patients with PNPO deficiency responded favorably to PLP therapy. In most instances, this manifested as an increase in seizure frequency following the transition from PN or the tapering of PN in favor of PLP. These patients may have specific <em>PNPO</em> mutations that make them more responsive to PN than PLP, which has been proposed for the c.674G&gt;A (p.Arg225His) variant [<a href="#jimd70074-bib-0034" class="usa-link" aria-describedby="jimd70074-bib-0034">34</a>]. However, most of the studies reporting these cases lacked sufficient detail on PLP therapy, making it difficult to discern whether these seizures were truly unresponsive or if inadequate PLP therapy, such as suboptimal dosing and administration frequency, contributed to a poor response. Another limitation of this study relates to the association between PLP therapy and developmental outcomes. While PLP‐responsive patients with normal neurodevelopment appear to have been treated early, approximately one‐third of patients exhibited severe developmental delays, including one case where PLP therapy was initiated as early as day 5 [<a href="#jimd70074-bib-0002" class="usa-link" aria-describedby="jimd70074-bib-0002">2</a>]. Isolating PLP therapy‐related effects on development from other factors that may have contributed to poorer developmental outcomes, such as prior seizures and encephalopathy in infancy, is challenging. Additionally, this review did not include data on other potential influences, such as pre‐ and perinatal complications (fetal distress, premature birth) [<a href="#jimd70074-bib-0008" class="usa-link" aria-describedby="jimd70074-bib-0008">8</a>].</p>
<p>The most common side effect of PLP therapy was hepatotoxicity, reported in one in five cases and ranging from elevated transaminases to cirrhosis. Worryingly, there are (yet unpublished) reports of hepatocellular carcinoma (HCC) occurring in PNPO deficiency patients on long‐term PLP therapy [<a href="#jimd70074-bib-0043" class="usa-link" aria-describedby="jimd70074-bib-0043">43</a>]. 30% of pediatric HCC cases arise in the context of chronic liver conditions, including cirrhosis and metabolic disorders, as well as chronic viral hepatitis or cholestasis [<a href="#jimd70074-bib-0044" class="usa-link" aria-describedby="jimd70074-bib-0044">44</a>, <a href="#jimd70074-bib-0045" class="usa-link" aria-describedby="jimd70074-bib-0045">45</a>]. Since PLP is not authorized as a medicinal product, there are no established safety monitoring systems, and the reporting of such (serious) adverse events relies heavily on case reports published by individual clinicians. This introduces the possibility of underreporting. In this review, the mean duration of PLP usage documented was three years, which may prevent the identification of long‐term adverse effects such as cirrhosis and, potentially, HCC.</p>
<p>The mechanism responsible for the liver toxicity observed is not yet known. A single case of hepatoxicity linked to high‐dose PLP in a boy with homocystinuria perhaps suggests this may be attributable to PLP therapy rather than the inherent pathological mechanisms of PNPO deficiency [<a href="#jimd70074-bib-0046" class="usa-link" aria-describedby="jimd70074-bib-0046">46</a>]. It has been hypothesized that PLP metabolites or PLP degradation products may be the cause of liver toxicity, which might also relate to the insufficient quality of PLP food supplements for PNPO deficiency patients. Coman et al. posed that high‐dose PLP may trigger an abnormal, fibrogenic response in hepatic stellate cells via purinoceptor activation and thereby contribute to cirrhosis [<a href="#jimd70074-bib-0011" class="usa-link" aria-describedby="jimd70074-bib-0011">11</a>]. The high chemical reactivity of PLP may also be of toxicological relevance. PLP can non‐enzymatically modify metabolites and proteins by forming Schiff bases and inducing epimerization, both of which can alter protein structure and function [<a href="#jimd70074-bib-0047" class="usa-link" aria-describedby="jimd70074-bib-0047">47</a>, <a href="#jimd70074-bib-0048" class="usa-link" aria-describedby="jimd70074-bib-0048">48</a>]. It also reacts with lysine residues [<a href="#jimd70074-bib-0049" class="usa-link" aria-describedby="jimd70074-bib-0049">49</a>]. Acetaldehyde, a similarly reactive aldehyde, has been shown to impair Δ4‐3‐oxosteroid 5β‐reductase in the liver through lysine modification, leading to toxic metabolite accumulation and hepatic injury [<a href="#jimd70074-bib-0050" class="usa-link" aria-describedby="jimd70074-bib-0050">50</a>]. PLP may likewise impair critical hepatic enzymes, indicating a broader role in aldehyde‐mediated toxicity.</p>
<p>Another potential mechanism involves PLP degradation by intestinal bacteria, which typically synthesize B6 vitamers but may break down excess PLP into α,β‐unsaturated carbonyl compounds [<a href="#jimd70074-bib-0004" class="usa-link" aria-describedby="jimd70074-bib-0004">4</a>, <a href="#jimd70074-bib-0051" class="usa-link" aria-describedby="jimd70074-bib-0051">51</a>]. In tyrosinemia type 1 (OMIM #276700), fumaryl acetoacetate accumulation, another α,β‐unsaturated carbonyl compound, is linked to cirrhosis and HCC [<a href="#jimd70074-bib-0052" class="usa-link" aria-describedby="jimd70074-bib-0052">52</a>]. Alternatively, Mohamed‐Ahmed et al. suggest that 4‐pyridoxic acid 5′‐phosphate (PAP), a product of PLP (photo)degradation normally absent in humans, could inhibit PLP‐dependent enzymes and thereby play a role in hepatotoxicity [<a href="#jimd70074-bib-0001" class="usa-link" aria-describedby="jimd70074-bib-0001">1</a>]. The potential for PLP degradation is increased by the common practice of dissolving capsules or crushing tablets before administration to pediatric patients [<a href="#jimd70074-bib-0001" class="usa-link" aria-describedby="jimd70074-bib-0001">1</a>, <a href="#jimd70074-bib-0002" class="usa-link" aria-describedby="jimd70074-bib-0002">2</a>, <a href="#jimd70074-bib-0011" class="usa-link" aria-describedby="jimd70074-bib-0011">11</a>]. This administration method also increases the risk of dosing errors, as not only the dose accuracy but also the solubility of PLP food supplements can vary [<a href="#jimd70074-bib-0001" class="usa-link" aria-describedby="jimd70074-bib-0001">1</a>].</p>
<p>Overall, these findings demonstrate strong observational evidence for the effectiveness of PLP therapy in PNPO deficiency, while also showing the potential for hepatotoxicity that may be linked to high‐dose PLP. PNPO deficiency is in the minority of treatable IMDs, but patients require continuous, reliable, and precise dosing within a small therapeutic window to prevent life‐threatening seizures. Therefore, there is an urgent and unmet medical need for a high‐quality PLP product [<a href="#jimd70074-bib-0001" class="usa-link" aria-describedby="jimd70074-bib-0001">1</a>]. Authorization of PLP as a medicinal product would ensure dose accuracy as well as expand safety monitoring [<a href="#jimd70074-bib-0053" class="usa-link" aria-describedby="jimd70074-bib-0053">53</a>]. A report of incidental rectal PLP administration raises the possibility of developing alternative PLP formulations that would theoretically bypass the hepatic first‐pass metabolism, which may decrease the risk of therapy‐related liver injury [<a href="#jimd70074-bib-0011" class="usa-link" aria-describedby="jimd70074-bib-0011">11</a>]. Alternatively, an extended release formulation might be able to reduce the daily PLP dosage while maintaining therapeutic levels. More precise dosing evaluation may also help optimize PLP treatment. Though initially proposed as a diagnostic tool in PNPO deficiency, B6 vitamer measurement in plasma may possibly offer the potential for more detailed treatment monitoring [<a href="#jimd70074-bib-0054" class="usa-link" aria-describedby="jimd70074-bib-0054">54</a>, <a href="#jimd70074-bib-0055" class="usa-link" aria-describedby="jimd70074-bib-0055">55</a>]. However, its clinical implementation requires the development of validated reference ranges. In the meantime, the management of PNPO deficiency patients on PLP therapy should incorporate systematic screening for the development of liver disease.</p></section><section id="jimd70074-sec-0016"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>C.E.M.H., A.M.B., and N.N.S. conceptualized the review. N.N.S., L.v.D., and A.M.B. developed the systematic review protocol, including inclusion/exclusion criteria, search strategy, and data extraction forms. N.N.S., N.D.R., and L.v.D. were responsible for the screening and selection of studies, data extraction, and quality assessment. N.N.S. performed the data analysis, with C.E.M.H., A.M.B., L.v.D., M.M.M.G.B., and B.J. assisting with data interpretation. P.T.C. contributed to the interpretation of results and development of the discussion section. The original draft of the manuscript was prepared by N.N.S. A.M.B. supervised the project. All authors reviewed, edited, and approved the final manuscript for submission.</p></section><section id="jimd70074-sec-0018"><h2 class="pmc_sec_title">Ethics Statement</h2>
<p>Ethics approval was not required by our institution, as this study did not involve any patient‐related data or patient participation.</p></section><section id="jimd70074-sec-0017"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>C.E.M.H. is a member of the advisory committee to the insured healthcare package (Dutch Healthcare Institute), member of round table on orphan drugs (Dutch Healthcare Institute), executive member of the RARE‐NL foundation and chair of “Medicines for Society” (Medicijn voor de Maatschappij). Medicines for Society is an academic initiative that aims to support sustainable access to medicines for rare diseases, including PLP. N.N.S. and N.D.R. are members of Medicines for Society. Before working on this submission, N.D.R. held a position at IQVIA. A.M.B. reports membership of the international Galactosemia Network without remuneration. L.v.D., M.M.M.G.B., B.J., and P.T.C. have no conflicts of interest to disclose.</p></section><section id="sec19"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="jimd70074-supitem-0001"><div class="caption p"><p>
<strong>Data S1:</strong> Supporting Information.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12317649/bin/JIMD-48-0-s002.xlsx" data-ga-action="click_feat_suppl" class="usa-link">JIMD-48-0-s002.xlsx</a><sup> (14.6KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="jimd70074-supitem-0002"><div class="caption p"><p>
<strong>Data S2:</strong> Supporting Information.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12317649/bin/JIMD-48-0-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">JIMD-48-0-s001.docx</a><sup> (96.3KB, docx) </sup>
</div></div></section></section><section id="notes1"><p>

Stolwijk N. N., van Dussen L., Reijnhout N. D., et al., “Effectiveness of Pyridoxal‐5′‐Phosphate in PNPO Deficiency: A Systematic Review,” Journal of Inherited Metabolic Disease
48, no. 5 (2025): e70074, 10.1002/jimd.70074.
</p>
<section id="jimd70074-ntgp-0001" class="fn-group"><div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="jimd70074-note-0001"><p>
<strong>Funding:</strong> Nina N. Stolwijk, Niels D. Reijnhout, and Carla E. M. Hollak are members of the platform Medicine for Society (Medicijn voor de Maatschappij), for which funding is provided by the Postcodeloterij.</p></div></div></section></section><section id="jimd70074-sec-0020"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p></section><section id="jimd70074-bibl-0001" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="jimd70074-bibl-0001_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="jimd70074-bib-0001">
<span class="label">1.</span><cite>
Mohamed‐Ahmed A. H., Wilson M. P., Albuera M., et al., “Quality and Stability of Extemporaneous Pyridoxal Phosphate Preparations Used in the Treatment of Paediatric Epilepsy,” Journal of Pharmacy and Pharmacology
69, no. 4 (2017): 480–488, 10.1111/jphp.12701.
</cite> [<a href="https://doi.org/10.1111/jphp.12701" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28220480/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Pharmacy%20and%20Pharmacology&amp;title=Quality%20and%20Stability%20of%20Extemporaneous%20Pyridoxal%20Phosphate%20Preparations%20Used%20in%20the%20Treatment%20of%20Paediatric%20Epilepsy&amp;author=A.%20H.%20Mohamed%E2%80%90Ahmed&amp;author=M.%20P.%20Wilson&amp;author=M.%20Albuera&amp;volume=69&amp;issue=4&amp;publication_year=2017&amp;pages=480-488&amp;pmid=28220480&amp;doi=10.1111/jphp.12701&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0002">
<span class="label">2.</span><cite>
Stolwijk N. N., Brands M. M., Smit L. S., van der Wel V., Hollak C. E. M., and van Karnebeek C. D., “A Vitamin a Day Keeps the Doctor Away: The Need for High Quality Pyridoxal‐5′‐Phosphate,” European Journal of Paediatric Neurology
39 (2022): 25–29, 10.1016/j.ejpn.2022.04.011.
</cite> [<a href="https://doi.org/10.1016/j.ejpn.2022.04.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35636100/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Paediatric%20Neurology&amp;title=A%20Vitamin%20a%20Day%20Keeps%20the%20Doctor%20Away:%20The%20Need%20for%20High%20Quality%20Pyridoxal%E2%80%905%E2%80%B2%E2%80%90Phosphate&amp;author=N.%20N.%20Stolwijk&amp;author=M.%20M.%20Brands&amp;author=L.%20S.%20Smit&amp;author=V.%20van%20der%20Wel&amp;author=C.%20E.%20M.%20Hollak&amp;volume=39&amp;publication_year=2022&amp;pages=25-29&amp;pmid=35636100&amp;doi=10.1016/j.ejpn.2022.04.011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0003">
<span class="label">3.</span><cite>
di Salvo M. L., Contestabile R., and Safo M. K., “Vitamin B(6) Salvage Enzymes: Mechanism, Structure and Regulation,” Biochimica et Biophysica Acta
1814, no. 11 (2011): 1597–1608, 10.1016/j.bbapap.2010.12.006.
</cite> [<a href="https://doi.org/10.1016/j.bbapap.2010.12.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21182989/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochimica%20et%20Biophysica%20Acta&amp;title=Vitamin%20B(6)%20Salvage%20Enzymes:%20Mechanism,%20Structure%20and%20Regulation&amp;author=M.%20L.%20di%20Salvo&amp;author=R.%20Contestabile&amp;author=M.%20K.%20Safo&amp;volume=1814&amp;issue=11&amp;publication_year=2011&amp;pages=1597-1608&amp;pmid=21182989&amp;doi=10.1016/j.bbapap.2010.12.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0004">
<span class="label">4.</span><cite>
Wilson M. P., Plecko B., Mills P. B., and Clayton P. T., “Disorders Affecting Vitamin B(6) Metabolism,” Journal of Inherited Metabolic Disease
42, no. 4 (2019): 629–646, 10.1002/jimd.12060.
</cite> [<a href="https://doi.org/10.1002/jimd.12060" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30671974/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Inherited%20Metabolic%20Disease&amp;title=Disorders%20Affecting%20Vitamin%20B(6)%20Metabolism&amp;author=M.%20P.%20Wilson&amp;author=B.%20Plecko&amp;author=P.%20B.%20Mills&amp;author=P.%20T.%20Clayton&amp;volume=42&amp;issue=4&amp;publication_year=2019&amp;pages=629-646&amp;pmid=30671974&amp;doi=10.1002/jimd.12060&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0005">
<span class="label">5.</span><cite>
Barile A., Nogués I., di Salvo M. L., Bunik V., Contestabile R., and Tramonti A., “Molecular Characterization of Pyridoxine 5′‐Phosphate Oxidase and Its Pathogenic Forms Associated With Neonatal Epileptic Encephalopathy,” Scientific Reports
10, no. 1 (2020): 13621, 10.1038/s41598-020-70598-7.
</cite> [<a href="https://doi.org/10.1038/s41598-020-70598-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7424515/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32788630/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scientific%20Reports&amp;title=Molecular%20Characterization%20of%20Pyridoxine%205%E2%80%B2%E2%80%90Phosphate%20Oxidase%20and%20Its%20Pathogenic%20Forms%20Associated%20With%20Neonatal%20Epileptic%20Encephalopathy&amp;author=A.%20Barile&amp;author=I.%20Nogu%C3%A9s&amp;author=M.%20L.%20di%20Salvo&amp;author=V.%20Bunik&amp;author=R.%20Contestabile&amp;volume=10&amp;issue=1&amp;publication_year=2020&amp;pages=13621&amp;pmid=32788630&amp;doi=10.1038/s41598-020-70598-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0006">
<span class="label">6.</span><cite>
Mills P. B., Surtees R. A. H., Champion M. P., et al., “Neonatal Epileptic Encephalopathy Caused by Mutations in the PNPO Gene Encoding Pyridox(Am)ine 5′‐Phosphate Oxidase,” Human Molecular Genetics
14, no. 8 (2005): 1077–1086, 10.1093/hmg/ddi120.
</cite> [<a href="https://doi.org/10.1093/hmg/ddi120" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15772097/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Human%20Molecular%20Genetics&amp;title=Neonatal%20Epileptic%20Encephalopathy%20Caused%20by%20Mutations%20in%20the%20PNPO%20Gene%20Encoding%20Pyridox(Am)ine%205%E2%80%B2%E2%80%90Phosphate%20Oxidase&amp;author=P.%20B.%20Mills&amp;author=R.%20A.%20H.%20Surtees&amp;author=M.%20P.%20Champion&amp;volume=14&amp;issue=8&amp;publication_year=2005&amp;pages=1077-1086&amp;pmid=15772097&amp;doi=10.1093/hmg/ddi120&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0007">
<span class="label">7.</span><cite>

C. R.
Coughlin, 2nd
, Tseng L. A., Abdenur J. E., et al., “Consensus Guidelines for the Diagnosis and Management of Pyridoxine‐Dependent Epilepsy due to α‐Aminoadipic Semialdehyde Dehydrogenase Deficiency,” Journal of Inherited Metabolic Disease
44, no. 1 (2021): 178–192, 10.1002/jimd.12332.
</cite> [<a href="https://doi.org/10.1002/jimd.12332" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33200442/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Inherited%20Metabolic%20Disease&amp;title=Consensus%20Guidelines%20for%20the%20Diagnosis%20and%20Management%20of%20Pyridoxine%E2%80%90Dependent%20Epilepsy%20due%20to%20%CE%B1%E2%80%90Aminoadipic%20Semialdehyde%20Dehydrogenase%20Deficiency&amp;author=C.%20R.%20Coughlin&amp;author=L.%20A.%20Tseng&amp;author=J.%20E.%20Abdenur&amp;volume=44&amp;issue=1&amp;publication_year=2021&amp;pages=178-192&amp;pmid=33200442&amp;doi=10.1002/jimd.12332&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0008">
<span class="label">8.</span><cite>
Alghamdi M., Bashiri F. A., Abdelhakim M., et al., “Phenotypic and Molecular Spectrum of Pyridoxamine‐5′‐Phosphate Oxidase Deficiency: A Scoping Review of 87 Cases of Pyridoxamine‐5′‐Phosphate Oxidase Deficiency,” Clinical Genetics
99, no. 1 (2021): 99–110, 10.1111/cge.13843.
</cite> [<a href="https://doi.org/10.1111/cge.13843" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7820968/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32888189/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Genetics&amp;title=Phenotypic%20and%20Molecular%20Spectrum%20of%20Pyridoxamine%E2%80%905%E2%80%B2%E2%80%90Phosphate%20Oxidase%20Deficiency:%20A%20Scoping%20Review%20of%2087%20Cases%20of%20Pyridoxamine%E2%80%905%E2%80%B2%E2%80%90Phosphate%20Oxidase%20Deficiency&amp;author=M.%20Alghamdi&amp;author=F.%20A.%20Bashiri&amp;author=M.%20Abdelhakim&amp;volume=99&amp;issue=1&amp;publication_year=2021&amp;pages=99-110&amp;pmid=32888189&amp;doi=10.1111/cge.13843&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0009">
<span class="label">9.</span><cite>
Pressler R. M., Abend N. S., Auvin S., et al., “Treatment of Seizures in the Neonate: Guidelines and Consensus‐Based Recommendations‐Special Report From the ILAE Task Force on Neonatal Seizures,” Epilepsia
64, no. 10 (2023): 2550–2570, 10.1111/epi.17745.
</cite> [<a href="https://doi.org/10.1111/epi.17745" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37655702/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Epilepsia&amp;title=Treatment%20of%20Seizures%20in%20the%20Neonate:%20Guidelines%20and%20Consensus%E2%80%90Based%20Recommendations%E2%80%90Special%20Report%20From%20the%20ILAE%20Task%20Force%20on%20Neonatal%20Seizures&amp;author=R.%20M.%20Pressler&amp;author=N.%20S.%20Abend&amp;author=S.%20Auvin&amp;volume=64&amp;issue=10&amp;publication_year=2023&amp;pages=2550-2570&amp;pmid=37655702&amp;doi=10.1111/epi.17745&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0010">
<span class="label">10.</span><cite>
Sudarsanam A., Singh H., Wilcken B., et al., Cirrhosis Associated With Pyridoxal 5′‐Phosphate Treatment of Pyridoxamine 5′‐Phosphate Oxidase Deficiency, vol. 17 (JIMD Reports, 2014), 67–70, 10.1007/8904_2014_338.</cite> [<a href="https://doi.org/10.1007/8904_2014_338" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4241198/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25256445/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?title=Cirrhosis%20Associated%20With%20Pyridoxal%205%E2%80%B2%E2%80%90Phosphate%20Treatment%20of%20Pyridoxamine%205%E2%80%B2%E2%80%90Phosphate%20Oxidase%20Deficiency&amp;author=A.%20Sudarsanam&amp;author=H.%20Singh&amp;author=B.%20Wilcken&amp;publication_year=2014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0011">
<span class="label">11.</span><cite>
Coman D., Lewindon P., Clayton P., and Riney K., “PNPO Deficiency and Cirrhosis: Expanding the Clinical Phenotype?,” JIMD Reports
2016, no. 25 (2016): 71–75, 10.1007/8904_2015_456.</cite> [<a href="https://doi.org/10.1007/8904_2015_456" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5059209/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26108646/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JIMD%20Reports&amp;title=PNPO%20Deficiency%20and%20Cirrhosis:%20Expanding%20the%20Clinical%20Phenotype?&amp;author=D.%20Coman&amp;author=P.%20Lewindon&amp;author=P.%20Clayton&amp;author=K.%20Riney&amp;volume=2016&amp;issue=25&amp;publication_year=2016&amp;pages=71-75&amp;pmid=26108646&amp;doi=10.1007/8904_2015_456&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0012">
<span class="label">12.</span><cite>
Camp K. M., Lloyd‐Puryear M. A., and Huntington K. L., “Nutritional Treatment for Inborn Errors of Metabolism: Indications, Regulations, and Availability of Medical Foods and Dietary Supplements Using Phenylketonuria as an Example,” Molecular Genetics and Metabolism
107, no. 1–2 (2012): 3–9, 10.1016/j.ymgme.2012.07.005.
</cite> [<a href="https://doi.org/10.1016/j.ymgme.2012.07.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3444638/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22854513/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Genetics%20and%20Metabolism&amp;title=Nutritional%20Treatment%20for%20Inborn%20Errors%20of%20Metabolism:%20Indications,%20Regulations,%20and%20Availability%20of%20Medical%20Foods%20and%20Dietary%20Supplements%20Using%20Phenylketonuria%20as%20an%20Example&amp;author=K.%20M.%20Camp&amp;author=M.%20A.%20Lloyd%E2%80%90Puryear&amp;author=K.%20L.%20Huntington&amp;volume=107&amp;issue=1%E2%80%932&amp;publication_year=2012&amp;pages=3-9&amp;pmid=22854513&amp;doi=10.1016/j.ymgme.2012.07.005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0013">
<span class="label">13.</span><cite>
Ruiz A., García‐Villoria J., Ormazabal A., et al., “A New Fatal Case of Pyridox(Am)ine 5′‐Phosphate Oxidase (PNPO) Deficiency,” 93, no. 2 (2008): 216–218, 10.1016/j.ymgme.2007.10.003.</cite> [<a href="https://doi.org/10.1016/j.ymgme.2007.10.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18024216/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ruiz%20A.,%20Garc%C3%ADa%E2%80%90Villoria%20J.,%20Ormazabal%20A.,%20et%C2%A0al.,%20%E2%80%9CA%20New%20Fatal%20Case%20of%20Pyridox(Am)ine%205%E2%80%B2%E2%80%90Phosphate%20Oxidase%20(PNPO)%20Deficiency,%E2%80%9D%2093,%20no.%202%20(2008):%20216%E2%80%93218,%2010.1016/j.ymgme.2007.10.003." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0014">
<span class="label">14.</span><cite>
Page M. J., McKenzie J. E., Bossuyt P. M., et al., “The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews,” BMJ
372 (2021): n71, 10.1136/bmj.n71.
</cite> [<a href="https://doi.org/10.1136/bmj.n71" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8005924/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33782057/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=The%20PRISMA%202020%20Statement:%20An%20Updated%20Guideline%20for%20Reporting%20Systematic%20Reviews&amp;author=M.%20J.%20Page&amp;author=J.%20E.%20McKenzie&amp;author=P.%20M.%20Bossuyt&amp;volume=372&amp;publication_year=2021&amp;pages=n71&amp;pmid=33782057&amp;doi=10.1136/bmj.n71&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0015">
<span class="label">15.</span><cite>
Ouzzani M., Hammady H., Fedorowicz Z., and Elmagarmid A., “Rayyan—A Web and Mobile App for Systematic Reviews,” Systematic Reviews
5, no. 1 (2016): 210, 10.1186/s13643-016-0384-4.
</cite> [<a href="https://doi.org/10.1186/s13643-016-0384-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5139140/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27919275/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Systematic%20Reviews&amp;title=Rayyan%E2%80%94A%20Web%20and%20Mobile%20App%20for%20Systematic%20Reviews&amp;author=M.%20Ouzzani&amp;author=H.%20Hammady&amp;author=Z.%20Fedorowicz&amp;author=A.%20Elmagarmid&amp;volume=5&amp;issue=1&amp;publication_year=2016&amp;pages=210&amp;pmid=27919275&amp;doi=10.1186/s13643-016-0384-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0016">
<span class="label">16.</span><cite>
Murad M. H., Sultan S., Haffar S., and Bazerbachi F., “Methodological Quality and Synthesis of Case Series and Case Reports,” BMJ Evidence‐Based Medicine
23, no. 2 (2018): 60–63, 10.1136/bmjebm-2017-110853.</cite> [<a href="https://doi.org/10.1136/bmjebm-2017-110853" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6234235/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29420178/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ%20Evidence%E2%80%90Based%20Medicine&amp;title=Methodological%20Quality%20and%20Synthesis%20of%20Case%20Series%20and%20Case%20Reports&amp;author=M.%20H.%20Murad&amp;author=S.%20Sultan&amp;author=S.%20Haffar&amp;author=F.%20Bazerbachi&amp;volume=23&amp;issue=2&amp;publication_year=2018&amp;pages=60-63&amp;pmid=29420178&amp;doi=10.1136/bmjebm-2017-110853&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0017">
<span class="label">17.</span><cite>
Alghamdi M., Arold S. T., Hasan H., and Bashiri F., “Pyridox(Am)ine 5′‐Phosphate Oxidase Deficiency: Severe Prenatal Presentation With Hypoxic Ischemic Encephalopathy,” Journal of Pediatric Epilepsy
8, no. 2 (2019): 49–55, 10.1055/s-0039-1697676.</cite> [<a href="https://doi.org/10.1055/s-0039-1697676" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Pediatric%20Epilepsy&amp;title=Pyridox(Am)ine%205%E2%80%B2%E2%80%90Phosphate%20Oxidase%20Deficiency:%20Severe%20Prenatal%20Presentation%20With%20Hypoxic%20Ischemic%20Encephalopathy&amp;author=M.%20Alghamdi&amp;author=S.%20T.%20Arold&amp;author=H.%20Hasan&amp;author=F.%20Bashiri&amp;volume=8&amp;issue=2&amp;publication_year=2019&amp;pages=49-55&amp;doi=10.1055/s-0039-1697676&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0018">
<span class="label">18.</span><cite>
Bagci S., Zschocke J., Hoffmann G. F., et al., “Pyridoxal Phosphate‐Dependent Neonatal Epileptic Encephalopathy,” 93, no. 2 (2008): F151–F152, 10.1136/adc.2006.115162.</cite> [<a href="https://doi.org/10.1136/adc.2006.115162" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18296573/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bagci%20S.,%20Zschocke%20J.,%20Hoffmann%20G.%20F.,%20et%C2%A0al.,%20%E2%80%9CPyridoxal%20Phosphate%E2%80%90Dependent%20Neonatal%20Epileptic%20Encephalopathy,%E2%80%9D%2093,%20no.%202%20(2008):%20F151%E2%80%93F152,%2010.1136/adc.2006.115162." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0019">
<span class="label">19.</span><cite>
Balaji A., Mohanlal S., Pachat D., et al., “Genome‐Based Therapeutics: Era of Precision Medicine in Genetic Epilepsies and Epileptic Encephalopathies,” Annals of Indian Academy of Neurology
26, no. 5 (2023): 723–727, 10.4103/aian.aian_314_23.
</cite> [<a href="https://doi.org/10.4103/aian.aian_314_23" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10666847/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38022486/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20Indian%20Academy%20of%20Neurology&amp;title=Genome%E2%80%90Based%20Therapeutics:%20Era%20of%20Precision%20Medicine%20in%20Genetic%20Epilepsies%20and%20Epileptic%20Encephalopathies&amp;author=A.%20Balaji&amp;author=S.%20Mohanlal&amp;author=D.%20Pachat&amp;volume=26&amp;issue=5&amp;publication_year=2023&amp;pages=723-727&amp;pmid=38022486&amp;doi=10.4103/aian.aian_314_23&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0020">
<span class="label">20.</span><cite>
Borst A. J. and Tchapyjnikov D., “B(6) and Bleeding: A Case Report of a Novel Vitamin Toxicity,” Pediatrics
141, no. Suppl 5 (2018): S430–S433, 10.1542/peds.2017-2039.
</cite> [<a href="https://doi.org/10.1542/peds.2017-2039" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5877127/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29610166/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatrics&amp;title=B(6)%20and%20Bleeding:%20A%20Case%20Report%20of%20a%20Novel%20Vitamin%20Toxicity&amp;author=A.%20J.%20Borst&amp;author=D.%20Tchapyjnikov&amp;volume=141&amp;issue=Suppl%205&amp;publication_year=2018&amp;pages=S430-S433&amp;pmid=29610166&amp;doi=10.1542/peds.2017-2039&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0021">
<span class="label">21.</span><cite>
Cortès‐Saladelafont E., Molero‐Luis M., Hsjd Working Group
, et al., “Pyridoxal Phosphate Supplementation in Neuropediatric Disorders,” Seminars in Pediatric Neurology
23, no. 4 (2016): 351–358, 10.1016/j.spen.2016.11.009.
</cite> [<a href="https://doi.org/10.1016/j.spen.2016.11.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28284396/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Seminars%20in%20Pediatric%20Neurology&amp;title=Pyridoxal%20Phosphate%20Supplementation%20in%20Neuropediatric%20Disorders&amp;author=E.%20Cort%C3%A8s%E2%80%90Saladelafont&amp;author=M.%20Molero%E2%80%90Luis&amp;volume=23&amp;issue=4&amp;publication_year=2016&amp;pages=351-358&amp;pmid=28284396&amp;doi=10.1016/j.spen.2016.11.009&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0022">
<span class="label">22.</span><cite>
Farmania R., Gupta A., Ankur K., Chetry S., and Sharma S., “Complexities of Pyridoxine Response in PNPO Deficiency,” Epilepsy &amp; Behavior Reports
16 (2021): 100443, 10.1016/j.ebr.2021.100443.
</cite> [<a href="https://doi.org/10.1016/j.ebr.2021.100443" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8082192/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33981986/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Epilepsy%20&amp;%20Behavior%20Reports&amp;title=Complexities%20of%20Pyridoxine%20Response%20in%20PNPO%20Deficiency&amp;author=R.%20Farmania&amp;author=A.%20Gupta&amp;author=K.%20Ankur&amp;author=S.%20Chetry&amp;author=S.%20Sharma&amp;volume=16&amp;publication_year=2021&amp;pages=100443&amp;pmid=33981986&amp;doi=10.1016/j.ebr.2021.100443&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0023">
<span class="label">23.</span><cite>
Gowda V. P. and Srinivasan V. N., “Ohtahara and West Syndrome due to Pyridox(Am)ine‐5‐Phosphate Oxidase (PNPO) Deficiency With Novel Phenotype and Good Outcome Without Pyridoxal‐5′‐Phosphate,” Indian Journal of Pediatrics
90, no. 6 (2023): 623, 10.1007/s12098-023-04560-6.
</cite> [<a href="https://doi.org/10.1007/s12098-023-04560-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36922472/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Indian%20Journal%20of%20Pediatrics&amp;title=Ohtahara%20and%20West%20Syndrome%20due%20to%20Pyridox(Am)ine%E2%80%905%E2%80%90Phosphate%20Oxidase%20(PNPO)%20Deficiency%20With%20Novel%20Phenotype%20and%20Good%20Outcome%20Without%20Pyridoxal%E2%80%905%E2%80%B2%E2%80%90Phosphate&amp;author=V.%20P.%20Gowda&amp;author=V.%20N.%20Srinivasan&amp;volume=90&amp;issue=6&amp;publication_year=2023&amp;pages=623&amp;pmid=36922472&amp;doi=10.1007/s12098-023-04560-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0024">
<span class="label">24.</span><cite>
Goyal M., Fequiere P. R., McGrath T. M., and Hyland K., “Seizures With Decreased Levels of Pyridoxal Phosphate in Cerebrospinal Fluid,” Pediatric Neurology
48, no. 3 (2013): 227–231, 10.1016/j.pediatrneurol.2012.11.006.
</cite> [<a href="https://doi.org/10.1016/j.pediatrneurol.2012.11.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23419474/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatric%20Neurology&amp;title=Seizures%20With%20Decreased%20Levels%20of%20Pyridoxal%20Phosphate%20in%20Cerebrospinal%20Fluid&amp;author=M.%20Goyal&amp;author=P.%20R.%20Fequiere&amp;author=T.%20M.%20McGrath&amp;author=K.%20Hyland&amp;volume=48&amp;issue=3&amp;publication_year=2013&amp;pages=227-231&amp;pmid=23419474&amp;doi=10.1016/j.pediatrneurol.2012.11.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0025">
<span class="label">25.</span><cite>
Guerin A., Aziz A. S., Mutch C., Lewis J., Go C. Y., and Mercimek‐Mahmutoglu S., “Pyridox(Am)ine‐5‐Phosphate Oxidase Deficiency Treatable Cause of Neonatal Epileptic Encephalopathy With Burst Suppression: Case Report and Review of the Literature,” Journal of Child Neurology
30, no. 9 (2015): 1218–1225, 10.1177/0883073814550829.
</cite> [<a href="https://doi.org/10.1177/0883073814550829" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25296925/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Child%20Neurology&amp;title=Pyridox(Am)ine%E2%80%905%E2%80%90Phosphate%20Oxidase%20Deficiency%20Treatable%20Cause%20of%20Neonatal%20Epileptic%20Encephalopathy%20With%20Burst%20Suppression:%20Case%20Report%20and%20Review%20of%20the%20Literature&amp;author=A.%20Guerin&amp;author=A.%20S.%20Aziz&amp;author=C.%20Mutch&amp;author=J.%20Lewis&amp;author=C.%20Y.%20Go&amp;volume=30&amp;issue=9&amp;publication_year=2015&amp;pages=1218-1225&amp;pmid=25296925&amp;doi=10.1177/0883073814550829&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0026">
<span class="label">26.</span><cite>
Guerriero R. M., Patel A. A., Walsh B., et al., “Systemic Manifestations in Pyridox(Am)ine 5′‐Phosphate Oxidase Deficiency,” Pediatric Neurology
76 (2017): 47–53, 10.1016/j.pediatrneurol.2017.05.024.
</cite> [<a href="https://doi.org/10.1016/j.pediatrneurol.2017.05.024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6008785/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28985901/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatric%20Neurology&amp;title=Systemic%20Manifestations%20in%20Pyridox(Am)ine%205%E2%80%B2%E2%80%90Phosphate%20Oxidase%20Deficiency&amp;author=R.%20M.%20Guerriero&amp;author=A.%20A.%20Patel&amp;author=B.%20Walsh&amp;volume=76&amp;publication_year=2017&amp;pages=47-53&amp;pmid=28985901&amp;doi=10.1016/j.pediatrneurol.2017.05.024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0027">
<span class="label">27.</span><cite>
Hoffmann G., Schmitt B., Windfuhr M., et al., “Pyridoxal 5′‐Phosphate May Be Curative in Early‐Onset Epileptic Encephalopathy,” Journal of Inherited Metabolic Disease
30, no. 1 (2007): 96–99, 10.1007/s10545-006-0508-4.
</cite> [<a href="https://doi.org/10.1007/s10545-006-0508-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17216302/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Inherited%20Metabolic%20Disease&amp;title=Pyridoxal%205%E2%80%B2%E2%80%90Phosphate%20May%20Be%20Curative%20in%20Early%E2%80%90Onset%20Epileptic%20Encephalopathy&amp;author=G.%20Hoffmann&amp;author=B.%20Schmitt&amp;author=M.%20Windfuhr&amp;volume=30&amp;issue=1&amp;publication_year=2007&amp;pages=96-99&amp;pmid=17216302&amp;doi=10.1007/s10545-006-0508-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0028">
<span class="label">28.</span><cite>
Hatch J., Coman D., Clayton P., et al., “Normal Neurodevelopmental Outcomes in PNPO Deficiency: A Case Series and Literature Review,” JIMD Reports
2016, no. 26 (2016): 91–97, 10.1007/8904_2015_482.</cite> [<a href="https://doi.org/10.1007/8904_2015_482" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4864713/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26303608/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JIMD%20Reports&amp;title=Normal%20Neurodevelopmental%20Outcomes%20in%20PNPO%20Deficiency:%20A%20Case%20Series%20and%20Literature%20Review&amp;author=J.%20Hatch&amp;author=D.%20Coman&amp;author=P.%20Clayton&amp;volume=2016&amp;issue=26&amp;publication_year=2016&amp;pages=91-97&amp;pmid=26303608&amp;doi=10.1007/8904_2015_482&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0029">
<span class="label">29.</span><cite>
Jiao X., Gong P., Niu Y., Xu Z., Zhang Y., and Yang Z., “Analysis for Variable Manifestations and Molecular Characteristics of Pyridox(Am)ine‐5′‐Phosphate Oxidase (PNPO) Deficiency,” Human Molecular Genetics
32, no. 11 (2023): 1765–1771, 10.1093/hmg/ddac234.
</cite> [<a href="https://doi.org/10.1093/hmg/ddac234" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36106796/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Human%20Molecular%20Genetics&amp;title=Analysis%20for%20Variable%20Manifestations%20and%20Molecular%20Characteristics%20of%20Pyridox(Am)ine%E2%80%905%E2%80%B2%E2%80%90Phosphate%20Oxidase%20(PNPO)%20Deficiency&amp;author=X.%20Jiao&amp;author=P.%20Gong&amp;author=Y.%20Niu&amp;author=Z.%20Xu&amp;author=Y.%20Zhang&amp;volume=32&amp;issue=11&amp;publication_year=2023&amp;pages=1765-1771&amp;pmid=36106796&amp;doi=10.1093/hmg/ddac234&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0030">
<span class="label">30.</span><cite>
Jiao X., Gong P., Niu Y., Zhang Y., and Yang Z., “A Rare Presentation Characterized by Epileptic Spasms in ALDH7A1, Pyridox(Am)ine‐5′‐Phosphate Oxidase, and PLPBP Deficiency,” Frontiers in Genetics
13 (2022): 804461, 10.3389/fgene.2022.804461.
</cite> [<a href="https://doi.org/10.3389/fgene.2022.804461" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9039010/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35495162/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Genetics&amp;title=A%20Rare%20Presentation%20Characterized%20by%20Epileptic%20Spasms%20in%20ALDH7A1,%20Pyridox(Am)ine%E2%80%905%E2%80%B2%E2%80%90Phosphate%20Oxidase,%20and%20PLPBP%20Deficiency&amp;author=X.%20Jiao&amp;author=P.%20Gong&amp;author=Y.%20Niu&amp;author=Y.%20Zhang&amp;author=Z.%20Yang&amp;volume=13&amp;publication_year=2022&amp;pages=804461&amp;pmid=35495162&amp;doi=10.3389/fgene.2022.804461&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0031">
<span class="label">31.</span><cite>
Mills P. B., Camuzeaux S. S., Footitt E. J., et al., “Epilepsy due to PNPO Mutations: Genotype, Environment and Treatment Affect Presentation and Outcome,” Brain
137 (2014): 1350–1360, 10.1093/brain/awu051.
</cite> [<a href="https://doi.org/10.1093/brain/awu051" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3999720/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24645144/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Brain&amp;title=Epilepsy%20due%20to%20PNPO%20Mutations:%20Genotype,%20Environment%20and%20Treatment%20Affect%20Presentation%20and%20Outcome&amp;author=P.%20B.%20Mills&amp;author=S.%20S.%20Camuzeaux&amp;author=E.%20J.%20Footitt&amp;volume=137&amp;publication_year=2014&amp;pages=1350-1360&amp;pmid=24645144&amp;doi=10.1093/brain/awu051&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0032">
<span class="label">32.</span><cite>
Mohanlal S., Bindu P. S., Sureshbabu S., and Kumar S., “Variable Treatment Response in a Patient With Pyridoxal N Phosphate Oxidase (PNPO) Deficiency—Understanding the Paradox,” Epilepsy &amp; Behavior Reports
14 (2020): 100357, 10.1016/j.ebr.2020.100357.
</cite> [<a href="https://doi.org/10.1016/j.ebr.2020.100357" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7210397/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32395712/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Epilepsy%20&amp;%20Behavior%20Reports&amp;title=Variable%20Treatment%20Response%20in%20a%20Patient%20With%20Pyridoxal%20N%20Phosphate%20Oxidase%20(PNPO)%20Deficiency%E2%80%94Understanding%20the%20Paradox&amp;author=S.%20Mohanlal&amp;author=P.%20S.%20Bindu&amp;author=S.%20Sureshbabu&amp;author=S.%20Kumar&amp;volume=14&amp;publication_year=2020&amp;pages=100357&amp;pmid=32395712&amp;doi=10.1016/j.ebr.2020.100357&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0033">
<span class="label">33.</span><cite>
Pearl P. L., Hyland K., Chiles J., McGavin C. L., Yu Y., and Taylor D., Partial Pyridoxine Responsiveness in PNPO Deficiency, vol. 9 (JIMD Reports, 2013), 139–142, 10.1007/8904_2012_194.</cite> [<a href="https://doi.org/10.1007/8904_2012_194" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3565675/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23430561/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?title=Partial%20Pyridoxine%20Responsiveness%20in%20PNPO%20Deficiency&amp;author=P.%20L.%20Pearl&amp;author=K.%20Hyland&amp;author=J.%20Chiles&amp;author=C.%20L.%20McGavin&amp;author=Y.%20Yu&amp;publication_year=2013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0034">
<span class="label">34.</span><cite>
Plecko B., Paul K., Mills P., et al., “Pyridoxine Responsiveness in Novel Mutations of the PNPO Gene,” Neurology
82, no. 16 (2014): 1425–1433, 10.1212/WNL.0000000000000344.
</cite> [<a href="https://doi.org/10.1212/WNL.0000000000000344" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4001193/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24658933/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Pyridoxine%20Responsiveness%20in%20Novel%20Mutations%20of%20the%20PNPO%20Gene&amp;author=B.%20Plecko&amp;author=K.%20Paul&amp;author=P.%20Mills&amp;volume=82&amp;issue=16&amp;publication_year=2014&amp;pages=1425-1433&amp;pmid=24658933&amp;doi=10.1212/WNL.0000000000000344&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0035">
<span class="label">35.</span><cite>
Porri S., Fluss J., Plecko B., Paschke E., Korff C. M., and Kern I., “Positive Outcome Following Early Diagnosis and Treatment of Pyridoxal‐5′‐Phosphate Oxidase Deficiency: A Case Report,” 45, no. 1 (2014): 64–68, 10.1055/s-0033-1353489.</cite> [<a href="https://doi.org/10.1055/s-0033-1353489" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24297574/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Porri%20S.,%20Fluss%20J.,%20Plecko%20B.,%20Paschke%20E.,%20Korff%20C.%20M.,%20and%20Kern%20I.,%20%E2%80%9CPositive%20Outcome%20Following%20Early%20Diagnosis%20and%20Treatment%20of%20Pyridoxal%E2%80%905%E2%80%B2%E2%80%90Phosphate%20Oxidase%20Deficiency:%20A%20Case%20Report,%E2%80%9D%2045,%20no.%201%20(2014):%2064%E2%80%9368,%2010.1055/s-0033-1353489." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0036">
<span class="label">36.</span><cite>
Raimondi F., Mills P., Clayton P. T., and Del Giudice E., “A Preterm Neonate With Seizures Unresponsive to Conventional Treatment,” BML Case Reports
2015 (2015): bcr2015209743, 10.1136/bcr-2015-209743.</cite> [<a href="https://doi.org/10.1136/bcr-2015-209743" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4434345/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25979913/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BML%20Case%20Reports&amp;title=A%20Preterm%20Neonate%20With%20Seizures%20Unresponsive%20to%20Conventional%20Treatment&amp;author=F.%20Raimondi&amp;author=P.%20Mills&amp;author=P.%20T.%20Clayton&amp;author=E.%20Del%20Giudice&amp;volume=2015&amp;publication_year=2015&amp;pages=bcr2015209743&amp;pmid=25979913&amp;doi=10.1136/bcr-2015-209743&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0037">
<span class="label">37.</span><cite>
Schmitt B., Baumgartner M., Mills P. B., et al., “Seizures and Paroxysmal Events: Symptoms Pointing to the Diagnosis of Pyridoxine‐Dependent Epilepsy and Pyridoxine Phosphate Oxidase Deficiency,” 52, no. 7 (2010): e133–e142, 10.1111/j.1469-8749.2010.03660.x.</cite> [<a href="https://doi.org/10.1111/j.1469-8749.2010.03660.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20370816/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schmitt%20B.,%20Baumgartner%20M.,%20Mills%20P.%20B.,%20et%C2%A0al.,%20%E2%80%9CSeizures%20and%20Paroxysmal%20Events:%20Symptoms%20Pointing%20to%20the%20Diagnosis%20of%20Pyridoxine%E2%80%90Dependent%20Epilepsy%20and%20Pyridoxine%20Phosphate%20Oxidase%20Deficiency,%E2%80%9D%2052,%20no.%207%20(2010):%20e133%E2%80%93e142,%2010.1111/j.1469-8749.2010.03660.x." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0038">
<span class="label">38.</span><cite>
Veerapandiyan A., Winchester S. A., Gallentine W. B., et al., “Electroencephalographic and Seizure Manifestations of Pyridoxal 5′‐Phosphate‐Dependent Epilepsy,” Epilepsy &amp; Behavior
20, no. 3 (2011): 494–501, 10.1016/j.yebeh.2010.12.046.
</cite> [<a href="https://doi.org/10.1016/j.yebeh.2010.12.046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21292558/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Epilepsy%20&amp;%20Behavior&amp;title=Electroencephalographic%20and%20Seizure%20Manifestations%20of%20Pyridoxal%205%E2%80%B2%E2%80%90Phosphate%E2%80%90Dependent%20Epilepsy&amp;author=A.%20Veerapandiyan&amp;author=S.%20A.%20Winchester&amp;author=W.%20B.%20Gallentine&amp;volume=20&amp;issue=3&amp;publication_year=2011&amp;pages=494-501&amp;pmid=21292558&amp;doi=10.1016/j.yebeh.2010.12.046&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0039">
<span class="label">39.</span><cite>
Veeravigrom M., Damrongphol P., Ittiwut R., Ittiwut C., Suphapeetiporn K., and Shotelersuk V., “Pyridoxal 5′‐Phosphate‐Responsive Epilepsy With Novel Mutations in the PNPO Gene: A Case Report,” 14, no. 4 (2015): 14130–14135, 10.4238/2015.October.29.34.</cite> [<a href="https://doi.org/10.4238/2015.October.29.34" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26535729/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Veeravigrom%20M.,%20Damrongphol%20P.,%20Ittiwut%20R.,%20Ittiwut%20C.,%20Suphapeetiporn%20K.,%20and%20Shotelersuk%20V.,%20%E2%80%9CPyridoxal%205%E2%80%B2%E2%80%90Phosphate%E2%80%90Responsive%20Epilepsy%20With%20Novel%20Mutations%20in%20the%20PNPO%20Gene:%20A%20Case%20Report,%E2%80%9D%2014,%20no.%204%20(2015):%2014130%E2%80%9314135,%2010.4238/2015.October.29.34." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0040">
<span class="label">40.</span><cite>
Ware T. L., Earl J., Salomons G. S., et al., “Typical and Atypical Phenotypes of PNPO Deficiency With Elevated CSF and Plasma Pyridoxamine on Treatment,” Developmental Medicine and Child Neurology
56, no. 5 (2014): 498–502, 10.1111/dmcn.12346.
</cite> [<a href="https://doi.org/10.1111/dmcn.12346" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24266778/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Developmental%20Medicine%20and%20Child%20Neurology&amp;title=Typical%20and%20Atypical%20Phenotypes%20of%20PNPO%20Deficiency%20With%20Elevated%20CSF%20and%20Plasma%20Pyridoxamine%20on%20Treatment&amp;author=T.%20L.%20Ware&amp;author=J.%20Earl&amp;author=G.%20S.%20Salomons&amp;volume=56&amp;issue=5&amp;publication_year=2014&amp;pages=498-502&amp;pmid=24266778&amp;doi=10.1111/dmcn.12346&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0041">
<span class="label">41.</span><cite>
Xue J., Chang X., Zhang Y., and Yang Z., “Novel Phenotypes of Pyridox(Am)ine‐5′‐Phosphate Oxidase Deficiency and High Prevalence of c.445_448del Mutation in Chinese Patients,” 32, no. 4 (2017): 1081–1087, 10.1007/s11011-017-9995-2.</cite> [<a href="https://doi.org/10.1007/s11011-017-9995-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28349276/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xue%20J.,%20Chang%20X.,%20Zhang%20Y.,%20and%20Yang%20Z.,%20%E2%80%9CNovel%20Phenotypes%20of%20Pyridox(Am)ine%E2%80%905%E2%80%B2%E2%80%90Phosphate%20Oxidase%20Deficiency%20and%20High%20Prevalence%20of%20c.445_448del%20Mutation%20in%20Chinese%20Patients,%E2%80%9D%2032,%20no.%204%20(2017):%201081%E2%80%931087,%2010.1007/s11011-017-9995-2." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0042">
<span class="label">42.</span><cite>
Fung C. W., Kwong A. K., and Wong V. C., “Gene Panel Analysis for Nonsyndromic Cryptogenic Neonatal/Infantile Epileptic Encephalopathy,” Epilepsia Open
2, no. 2 (2017): 236–243, 10.1002/epi4.12055.
</cite> [<a href="https://doi.org/10.1002/epi4.12055" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5719849/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29588952/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Epilepsia%20Open&amp;title=Gene%20Panel%20Analysis%20for%20Nonsyndromic%20Cryptogenic%20Neonatal/Infantile%20Epileptic%20Encephalopathy&amp;author=C.%20W.%20Fung&amp;author=A.%20K.%20Kwong&amp;author=V.%20C.%20Wong&amp;volume=2&amp;issue=2&amp;publication_year=2017&amp;pages=236-243&amp;pmid=29588952&amp;doi=10.1002/epi4.12055&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0043">
<span class="label">43.</span><cite>
Webster R. S. B., Stormon M., Thomas G., et al., “Liver Transplantation in PNPO Deficiency: Management Challenges and Biological Lessons,” in Presented at: 14th International Congress of Inborn Errors of Metabolism (IEEE, 2021).</cite> [<a href="https://scholar.google.com/scholar_lookup?title=Presented%20at:%2014th%20International%20Congress%20of%20Inborn%20Errors%20of%20Metabolism&amp;author=R.%20S.%20B.%20Webster&amp;author=M.%20Stormon&amp;author=G.%20Thomas&amp;publication_year=2021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0044">
<span class="label">44.</span><cite>
Bosetti C., Turati F., and La Vecchia C., “Hepatocellular carcinoma epidemiology,” Best Practice &amp; Research. Clinical Gastroenterology
28, no. 5 (2014): 753–770, 10.1016/j.bpg.2014.08.007.
</cite> [<a href="https://doi.org/10.1016/j.bpg.2014.08.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25260306/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Best%20Practice%20&amp;%20Research.%20Clinical%20Gastroenterology&amp;title=Hepatocellular%20carcinoma%20epidemiology&amp;author=C.%20Bosetti&amp;author=F.%20Turati&amp;author=C.%20La%20Vecchia&amp;volume=28&amp;issue=5&amp;publication_year=2014&amp;pages=753-770&amp;pmid=25260306&amp;doi=10.1016/j.bpg.2014.08.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0045">
<span class="label">45.</span><cite>
Kelly D., Sharif K., Brown R. M., and Morland B., “Hepatocellular carcinoma in children,” Clinics in Liver Disease
19, no. 2 (2015): 433–447, 10.1016/j.cld.2015.01.010.
</cite> [<a href="https://doi.org/10.1016/j.cld.2015.01.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25921672/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinics%20in%20Liver%20Disease&amp;title=Hepatocellular%20carcinoma%20in%20children&amp;author=D.%20Kelly&amp;author=K.%20Sharif&amp;author=R.%20M.%20Brown&amp;author=B.%20Morland&amp;volume=19&amp;issue=2&amp;publication_year=2015&amp;pages=433-447&amp;pmid=25921672&amp;doi=10.1016/j.cld.2015.01.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0046">
<span class="label">46.</span><cite>
Yoshida I., Sakaguchi Y., Nakano M., Yamashita F., and Hitoshi T., “Pyridoxal Phosphate‐Induced Liver Injury in a Patient With Homocystinuria,” Journal of Inherited Metabolic Disease
8, no. 2 (1985): 91, 10.1007/bf01801674.
</cite> [<a href="https://doi.org/10.1007/bf01801674" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3939539/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Inherited%20Metabolic%20Disease&amp;title=Pyridoxal%20Phosphate%E2%80%90Induced%20Liver%20Injury%20in%20a%20Patient%20With%20Homocystinuria&amp;author=I.%20Yoshida&amp;author=Y.%20Sakaguchi&amp;author=M.%20Nakano&amp;author=F.%20Yamashita&amp;author=T.%20Hitoshi&amp;volume=8&amp;issue=2&amp;publication_year=1985&amp;pages=91&amp;pmid=3939539&amp;doi=10.1007/bf01801674&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0047">
<span class="label">47.</span><cite>
Kajita R., Goto T., Lee S. H., and Oe T., “Aldehyde Stress‐Mediated Novel Modification of Proteins: Epimerization of the N‐Terminal Amino Acid,” Chemical Research in Toxicology
26, no. 12 (2013): 1926–1936, 10.1021/tx400354d.
</cite> [<a href="https://doi.org/10.1021/tx400354d" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24299224/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chemical%20Research%20in%20Toxicology&amp;title=Aldehyde%20Stress%E2%80%90Mediated%20Novel%20Modification%20of%20Proteins:%20Epimerization%20of%20the%20N%E2%80%90Terminal%20Amino%20Acid&amp;author=R.%20Kajita&amp;author=T.%20Goto&amp;author=S.%20H.%20Lee&amp;author=T.%20Oe&amp;volume=26&amp;issue=12&amp;publication_year=2013&amp;pages=1926-1936&amp;pmid=24299224&amp;doi=10.1021/tx400354d&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0048">
<span class="label">48.</span><cite>
Reiber H., “Vitamin B‐6‐Catalyzed Beta‐Elimination of Serine and O‐Phosphoserine. Qualitative and Quantitative Aspects of Catalytic Influences at the Rate‐Limiting Step, a Comparison With the Rate of Enzymatic Beta‐Elimination,” Biochimica et Biophysica Acta
444, no. 3 (1976): 734–755, 10.1016/0304-4165(76)90321-4.
</cite> [<a href="https://doi.org/10.1016/0304-4165(76)90321-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10973/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochimica%20et%20Biophysica%20Acta&amp;title=Vitamin%20B%E2%80%906%E2%80%90Catalyzed%20Beta%E2%80%90Elimination%20of%20Serine%20and%20O%E2%80%90Phosphoserine.%20Qualitative%20and%20Quantitative%20Aspects%20of%20Catalytic%20Influences%20at%20the%20Rate%E2%80%90Limiting%20Step,%20a%20Comparison%20With%20the%20Rate%20of%20Enzymatic%20Beta%E2%80%90Elimination&amp;author=H.%20Reiber&amp;volume=444&amp;issue=3&amp;publication_year=1976&amp;pages=734-755&amp;pmid=10973&amp;doi=10.1016/0304-4165(76)90321-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0049">
<span class="label">49.</span><cite>
Katiyar S. S. and Porter J. W., “The Involvement of a Lysine Residue at the Active Site of the Enoyl Reductase of Pigeon Liver Fatty Acid Synthetase,” Biochemical and Biophysical Research Communications
107, no. 4 (1982): 1219–1223, 10.1016/s0006-291x(82)80127-7.
</cite> [<a href="https://doi.org/10.1016/s0006-291x(82)80127-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6814436/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemical%20and%20Biophysical%20Research%20Communications&amp;title=The%20Involvement%20of%20a%20Lysine%20Residue%20at%20the%20Active%20Site%20of%20the%20Enoyl%20Reductase%20of%20Pigeon%20Liver%20Fatty%20Acid%20Synthetase&amp;author=S.%20S.%20Katiyar&amp;author=J.%20W.%20Porter&amp;volume=107&amp;issue=4&amp;publication_year=1982&amp;pages=1219-1223&amp;pmid=6814436&amp;doi=10.1016/s0006-291x(82)80127-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0050">
<span class="label">50.</span><cite>
Lin R. C., Fillenwarth M. J., and Du X., “Cytotoxic Effect of 7alpha‐Hydroxy‐4‐Cholesten‐3‐One on HepG2 Cells: Hypothetical Role of Acetaldehyde‐Modified Delta4‐3‐Ketosteroid‐5beta‐Reductase (The 37‐Kd‐Liver Protein) in the Pathogenesis of Alcoholic Liver Injury in the Rat,” Hepatology
27, no. 1 (1998): 100–107, 10.1002/hep.510270117.
</cite> [<a href="https://doi.org/10.1002/hep.510270117" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9425924/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=Cytotoxic%20Effect%20of%207alpha%E2%80%90Hydroxy%E2%80%904%E2%80%90Cholesten%E2%80%903%E2%80%90One%20on%20HepG2%20Cells:%20Hypothetical%20Role%20of%20Acetaldehyde%E2%80%90Modified%20Delta4%E2%80%903%E2%80%90Ketosteroid%E2%80%905beta%E2%80%90Reductase%20(The%2037%E2%80%90Kd%E2%80%90Liver%20Protein)%20in%20the%20Pathogenesis%20of%20Alcoholic%20Liver%20Injury%20in%20the%20Rat&amp;author=R.%20C.%20Lin&amp;author=M.%20J.%20Fillenwarth&amp;author=X.%20Du&amp;volume=27&amp;issue=1&amp;publication_year=1998&amp;pages=100-107&amp;pmid=9425924&amp;doi=10.1002/hep.510270117&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0051">
<span class="label">51.</span><cite>
McCulloch K. M., Mukherjee T., Begley T. P., and Ealick S. E., “Structure Determination and Characterization of the Vitamin B6 Degradative Enzyme (E)‐2‐(Acetamidomethylene)succinate Hydrolase,” Biochemistry
49, no. 6 (2010): 1226–1235, 10.1021/bi901812p.
</cite> [<a href="https://doi.org/10.1021/bi901812p" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2849673/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20099871/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;title=Structure%20Determination%20and%20Characterization%20of%20the%20Vitamin%20B6%20Degradative%20Enzyme%20(E)%E2%80%902%E2%80%90(Acetamidomethylene)succinate%20Hydrolase&amp;author=K.%20M.%20McCulloch&amp;author=T.%20Mukherjee&amp;author=T.%20P.%20Begley&amp;author=S.%20E.%20Ealick&amp;volume=49&amp;issue=6&amp;publication_year=2010&amp;pages=1226-1235&amp;pmid=20099871&amp;doi=10.1021/bi901812p&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0052">
<span class="label">52.</span><cite>
Jorquera R. and Tanguay R. M., “Fumarylacetoacetate, the Metabolite Accumulating in Hereditary Tyrosinemia, Activates the ERK Pathway and Induces Mitotic Abnormalities and Genomic Instability,” Human Molecular Genetics
10, no. 17 (2001): 1741–1752, 10.1093/hmg/10.17.1741.
</cite> [<a href="https://doi.org/10.1093/hmg/10.17.1741" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11532983/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Human%20Molecular%20Genetics&amp;title=Fumarylacetoacetate,%20the%20Metabolite%20Accumulating%20in%20Hereditary%20Tyrosinemia,%20Activates%20the%20ERK%20Pathway%20and%20Induces%20Mitotic%20Abnormalities%20and%20Genomic%20Instability&amp;author=R.%20Jorquera&amp;author=R.%20M.%20Tanguay&amp;volume=10&amp;issue=17&amp;publication_year=2001&amp;pages=1741-1752&amp;pmid=11532983&amp;doi=10.1093/hmg/10.17.1741&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0053">
<span class="label">53.</span><cite>
Stolwijk N. N., Bosch A. M., Bouwhuis N., et al., “Food or Medicine? A European Regulatory Perspective on Nutritional Therapy Products to Treat Inborn Errors of Metabolism,” Journal of Inherited Metabolic Disease
46, no. 6 (2023): 1017–1028, 10.1002/jimd.12677.
</cite> [<a href="https://doi.org/10.1002/jimd.12677" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37650776/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Inherited%20Metabolic%20Disease&amp;title=Food%20or%20Medicine?%20A%20European%20Regulatory%20Perspective%20on%20Nutritional%20Therapy%20Products%20to%20Treat%20Inborn%20Errors%20of%20Metabolism&amp;author=N.%20N.%20Stolwijk&amp;author=A.%20M.%20Bosch&amp;author=N.%20Bouwhuis&amp;volume=46&amp;issue=6&amp;publication_year=2023&amp;pages=1017-1028&amp;pmid=37650776&amp;doi=10.1002/jimd.12677&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0054">
<span class="label">54.</span><cite>
Footitt E. J., Clayton P. T., Mills K., et al., “Measurement of Plasma B6 Vitamer Profiles in Children With Inborn Errors of Vitamin B6 Metabolism Using an LC‐MS/MS Method,” Journal of Inherited Metabolic Disease
36, no. 1 (2013): 139–145, 10.1007/s10545-012-9493-y.
</cite> [<a href="https://doi.org/10.1007/s10545-012-9493-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22576361/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Inherited%20Metabolic%20Disease&amp;title=Measurement%20of%20Plasma%20B6%20Vitamer%20Profiles%20in%20Children%20With%20Inborn%20Errors%20of%20Vitamin%20B6%20Metabolism%20Using%20an%20LC%E2%80%90MS/MS%20Method&amp;author=E.%20J.%20Footitt&amp;author=P.%20T.%20Clayton&amp;author=K.%20Mills&amp;volume=36&amp;issue=1&amp;publication_year=2013&amp;pages=139-145&amp;pmid=22576361&amp;doi=10.1007/s10545-012-9493-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="jimd70074-bib-0055">
<span class="label">55.</span><cite>
Mathis D., Abela L., Albersen M., et al., “The Value of Plasma Vitamin B6 Profiles in Early Onset Epileptic Encephalopathies,” Journal of Inherited Metabolic Disease
39, no. 5 (2016): 733–741, 10.1007/s10545-016-9955-8.
</cite> [<a href="https://doi.org/10.1007/s10545-016-9955-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27342130/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Inherited%20Metabolic%20Disease&amp;title=The%20Value%20of%20Plasma%20Vitamin%20B6%20Profiles%20in%20Early%20Onset%20Epileptic%20Encephalopathies&amp;author=D.%20Mathis&amp;author=L.%20Abela&amp;author=M.%20Albersen&amp;volume=39&amp;issue=5&amp;publication_year=2016&amp;pages=733-741&amp;pmid=27342130&amp;doi=10.1007/s10545-016-9955-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><p>
<strong>Data S1:</strong> Supporting Information.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12317649/bin/JIMD-48-0-s002.xlsx" data-ga-action="click_feat_suppl" class="usa-link">JIMD-48-0-s002.xlsx</a><sup> (14.6KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p"><p>
<strong>Data S2:</strong> Supporting Information.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12317649/bin/JIMD-48-0-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">JIMD-48-0-s001.docx</a><sup> (96.3KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Journal of Inherited Metabolic Disease are provided here courtesy of <strong>Wiley</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1002/jimd.70074"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/JIMD-48-0.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (397.0 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12317649/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12317649/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12317649%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12317649/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12317649/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12317649/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40751583/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12317649/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40751583/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12317649/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12317649/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="zpB5XAxN033mAx5l126o5ZqR4bM2sQbOcbonE9NaKPxZyUVI9YzQ0mb2SWqUtSZC">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
